Chimeric	B-protein
oncoprotein	I-protein
E2a-Pbx1	B-protein
induces	O
apoptosis	O
of	O
hematopoietic	B-cell_type
cells	I-cell_type
by	O
a	O
p53	B-protein
-independent	O
mechanism	O
that	O
is	O
suppressed	O
by	O
Bcl-2	B-protein
.	O

The	O
chimeric	B-protein
oncoprotein	I-protein
E2a-Pbx1	B-protein
results	O
from	O
fusion	O
of	O
the	O
E2A	B-DNA
and	I-DNA
PBX1	I-DNA
genes	I-DNA
following	O
t	B-DNA
(	I-DNA
1	I-DNA
;	I-DNA
19	I-DNA
)	I-DNA
chromosomal	I-DNA
translocations	I-DNA
in	O
B	O
cell	O
precursor	O
acute	O
leukemias	O
.	O

Experimentally	O
B	B-cell_type
cell	I-cell_type
progenitors	I-cell_type
do	O
not	O
tolerate	O
constitutive	O
expression	O
of	O
E2a-Pbx1	B-protein
which	O
contrasts	O
with	O
transformation	O
of	O
several	O
other	O
cell	O
types	O
following	O
its	O
stable	O
expression	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

To	O
further	O
investigate	O
the	O
effects	O
of	O
E2a-Pbx1	B-protein
on	O
the	O
B	B-cell_type
cell	I-cell_type
progenitors	I-cell_type
,	O
we	O
conditionally	O
expressed	O
E2a-Pbx1	B-protein
under	O
control	O
of	O
a	O
metal	O
response	O
element	O
in	O
hematopoietic	B-cell_line
precursor	I-cell_line
cell	I-cell_line
lines	I-cell_line
in	O
vitro	O
.	O

Inducible	O
expression	O
of	O
E2a-Pbx1	B-protein
resulted	O
in	O
cell	O
death	O
with	O
the	O
morphologic	O
and	O
molecular	O
features	O
of	O
apoptosis	O
.	O

A	O
structure-function	O
analysis	O
demonstrated	O
that	O
induction	O
of	O
apoptosis	O
was	O
not	O
a	O
dominant-negative	O
effect	O
of	O
the	O
E2a	B-protein
moiety	I-protein
but	O
,	O
rather	O
,	O
required	O
the	O
DNA-binding	B-protein
homeodomain	I-protein
of	O
Pbx1	B-protein
.	O

E2a-	O
Pbx1	B-protein
-induced	O
apoptosis	O
proceeded	O
through	O
a	O
BCL2	B-protein
-responsive	O
checkpoint	O
eventuating	O
in	O
PARP	B-protein
inactivation	O
but	O
did	O
require	O
p53	B-protein
.	O

Constitutive	O
expression	O
of	O
E2a-Pbx1	B-protein
did	O
not	O
induce	O
apoptosis	O
or	O
continued	O
cycling	O
of	O
Rat-1	B-cell_line
fibroblasts	I-cell_line
in	O
low	O
serum	O
conditions	O
.	O

These	O
studies	O
demonstrate	O
that	O
E2a-Pbx1	B-protein
initiates	O
programmed	O
cell	O
death	O
of	O
hematopoietic	B-cell_type
precursers	I-cell_type
by	O
a	O
mechanism	O
that	O
requires	O
its	O
chimeric	O
transcriptional	O
properties	O
,	O
but	O
,	O
unlike	O
other	O
nuclear	B-protein
oncoproteins	I-protein
,	O
is	O
independent	O
of	O
p53	B-protein
.	O

Oncogene	NULL
(	NULL
1997	NULL
)	NULL
14	NULL
,	NULL
2917-2926	NULL
Â©	NULL
1997	NULL
Stockton	NULL
Press	NULL
All	NULL
rights	NULL
reserved	NULL
0950-9232/97	NULL
$	NULL
12.00	NULL
Chimeric	NULL
oncoprotein	NULL
E2a-Pbx1	NULL
induces	NULL
apoptosis	NULL
of	NULL
hematopoietic	NULL
cells	NULL
by	NULL
a	NULL
p53-independent	NULL
mechanism	NULL
that	NULL
is	NULL
suppressed	NULL
by	NULL
Bcel-2	NULL
Kevin	NULL
S	NULL
Smith	NULL
,	NULL
Yakop	NULL
Jacobs	NULL
,	NULL
Ching-Pin	NULL
Chang	NULL
and	NULL
Michael	NULL
L	NULL
Cleary	NULL
Laboratory	NULL
of	NULL
Experimental	NULL
Oncology	NULL
,	NULL
Department	NULL
of	NULL
Pathology	NULL
,	NULL
Stanford	NULL
University	NULL
Medical	NULL
Center	NULL
,	NULL
Stanford	NULL
,	NULL
California	NULL
94305	NULL
,	NULL
USA	NULL
The	NULL
chimeric	NULL
oncoprotein	NULL
E2a-Pbx1	NULL
results	NULL
from	NULL
fusion	NULL
of	NULL
the	NULL
E24	NULL
and	NULL
PBX	NULL
!	NULL

genes	NULL
following	NULL
t	NULL
(	NULL
1	NULL
;	NULL
19	NULL
)	NULL
chromosomal	NULL
translocations	NULL
in	NULL
B	NULL
cell	NULL
precursor	NULL
acute	NULL
leukemias	NULL
.	NULL

Experimentally	NULL
B	NULL
cell	NULL
progenitors	NULL
do	NULL
not	NULL
tolerate	NULL
constitutive	NULL
expression	NULL
of	NULL
E2a-Pbx1	NULL
which	NULL
contrasts	NULL
with	NULL
transformation	NULL
of	NULL
several	NULL
other	NULL
cell	NULL
types	NULL
following	NULL
its	NULL
stable	NULL
expression	NULL
both	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
.	NULL

To	NULL
further	NULL
investigate	NULL
the	NULL
effects	NULL
of	NULL
E2a-Pbx1	NULL
on	NULL
the	NULL
B	NULL
cell	NULL
progenitors	NULL
,	NULL
we	NULL
conditionally	NULL
expressed	NULL
E2Za-Pbx1	NULL
under	NULL
control	NULL
of	NULL
a	NULL
metal	NULL
response	NULL
element	NULL
in	NULL
hematopoietic	NULL
precursor	NULL
cell	NULL
lines	NULL
in	NULL
vitro	NULL
.	NULL

Inducible	NULL
expression	NULL
of	NULL
E2a-Pbx1	NULL
resulted	NULL
in	NULL
cell	NULL
death	NULL
with	NULL
the	NULL
morphologic	NULL
and	NULL
molecular	NULL
features	NULL
of	NULL
apoptosis	NULL
.	NULL

A	NULL
structure-function	NULL
analysis	NULL
demonstrated	NULL
that	NULL
induction	NULL
of	NULL
apoptosis	NULL
was	NULL
not	NULL
a	NULL
dominant-negative	NULL
effect	NULL
of	NULL
the	NULL
EZ2a	NULL
moiety	NULL
but	NULL
,	NULL
rather	NULL
,	NULL
required	NULL
the	NULL
DNA-binding	NULL
homeodomain	NULL
of	NULL
Pbx1	NULL
.	NULL

E2a-Pbx1-induced	NULL
apoptosis	NULL
proceeded	NULL
through	NULL
a	NULL
BCL2-responsive	NULL
checkpoint	NULL
eventuating	NULL
in	NULL
PARP	NULL
inactivation	NULL
but	NULL
did	NULL
require	NULL
p53	NULL
.	NULL

Constitutive	NULL
expression	NULL
of	NULL
E2a-Pbx1	NULL
did	NULL
not	NULL
induce	NULL
apoptosis	NULL
or	NULL
continued	NULL
cycling	NULL
of	NULL
Rat-1	NULL
fibroblasts	NULL
in	NULL
low	NULL
serum	NULL
conditions	NULL
.	NULL

These	NULL
studies	NULL
demonstrate	NULL
that	NULL
E2a-Pbx1	NULL
initiates	NULL
programmed	NULL
cell	NULL
death	NULL
of	NULL
hematopoietic	NULL
precursers	NULL
by	NULL
a	NULL
mechanism	NULL
that	NULL
requires	NULL
its	NULL
chimeric	NULL
transcriptional	NULL
properties	NULL
,	NULL
but	NULL
,	NULL
unlike	NULL
other	NULL
nuclear	NULL
oncoproteins	NULL
,	NULL
is	NULL
independent	NULL
of	NULL
pS3	NULL
.	NULL

Keywords	NULL
:	NULL
apoptosis	NULL
;	NULL
inducible	NULL
oncoprotein	NULL
;	NULL
transloca-tion	NULL
;	NULL
homeodomain	NULL
Introduction	NULL
Chromosomal	NULL
translocations	NULL
constitute	NULL
an	NULL
important	NULL
mechanism	NULL
by	NULL
which	NULL
cellular	NULL
proto-oncogenes	NULL
are	NULL
converted	NULL
to	NULL
oncogenes	NULL
in	NULL
human	NULL
cancers	NULL
.	NULL

Several	NULL
chromosomal	NULL
translocations	NULL
in	NULL
leukemias	NULL
lead	NULL
to	NULL
production	NULL
of	NULL
fusion	NULL
proteins	NULL
with	NULL
features	NULL
of	NULL
chimeric	NULL
transcription	NULL
factors	NULL
(	NULL
Cleary	NULL
,	NULL
1991	NULL
)	NULL
.	NULL

The	NULL
first	NULL
of	NULL
these	NULL
was	NULL
reported	NULL
in	NULL
pre	NULL
B	NULL
cell	NULL
acute	NULL
leukemias	NULL
,	NULL
where	NULL
the	NULL
t	NULL
(	NULL
1	NULL
;	NULL
19	NULL
)	NULL
translocation	NULL
results	NULL
in	NULL
expression	NULL
of	NULL
chimeric	NULL
oncoprotein	NULL
EZ2a-Pbx1	NULL
(	NULL
Kamps	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Nourse	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

One	NULL
of	NULL
the	NULL
genes	NULL
involved	NULL
in	NULL
this	NULL
translocation	NULL
,	NULL
E2A	NULL
,	NULL
codes	NULL
for	NULL
two	NULL
alternatively	NULL
spliced	NULL
transcription	NULL
factors	NULL
,	NULL
E12	NULL
and	NULL
E47	NULL
,	NULL
which	NULL
regulate	NULL
developmental	NULL
pathways	NULL
in	NULL
muscle	NULL
,	NULL
pancreatic	NULL
and	NULL
B	NULL
cells	NULL
(	NULL
Kadesch	NULL
,	NULL
1992	NULL
)	NULL
.	NULL

The	NULL
other	NULL
gene	NULL
,	NULL
PBX1	NULL
,	NULL
codes	NULL
for	NULL
a	NULL
highly	NULL
conserved	NULL
member	NULL
of	NULL
a	NULL
small	NULL
subfamily	NULL
of	NULL
divergent	NULL
homedomain-containing	NULL
proteins	NULL
with	NULL
unique	NULL
Correspondence	NULL
:	NULL
KS	NULL
Smith	NULL
Received	NULL
24	NULL
October	NULL
1996	NULL
;	NULL
revised	NULL
11	NULL
December	NULL
1996	NULL
;	NULL
accepted	NULL
16	NULL
December	NULL
1996	NULL
genetic	NULL
and	NULL
biochemical	NULL
properties	NULL
(	NULL
Monica	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

The	NULL
Drosophila	NULL
homolog	NULL
of	NULL
Pbx1	NULL
,	NULL
exd	NULL
,	NULL
has	NULL
been	NULL
shown	NULL
genetically	NULL
to	NULL
act	NULL
in	NULL
parallel	NULL
with	NULL
Hox	NULL
proteins	NULL
in	NULL
the	NULL
determination	NULL
of	NULL
segmental	NULL
identity	NULL
(	NULL
Rauskolb	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

A	NULL
similar	NULL
role	NULL
for	NULL
Pbx	NULL
proteins	NULL
is	NULL
suggested	NULL
by	NULL
their	NULL
potential	NULL
involvement	NULL
in	NULL
a	NULL
highly	NULL
conserved	NULL
autoregulatory	NULL
loop	NULL
that	NULL
controls	NULL
HoxBI1	NULL
expression	NULL
in	NULL
the	NULL
mouse	NULL
hindbrain	NULL
(	NULL
Popper	NULL
!	NULL

et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

Recent	NULL
biochemical	NULL
studies	NULL
support	NULL
a	NULL
role	NULL
for	NULL
Pbx/exd	NULL
proteins	NULL
as	NULL
DNA-binding	NULL
cofactors	NULL
for	NULL
Hox	NULL
proteins	NULL
(	NULL
reviewed	NULL
in	NULL
Mann	NULL
and	NULL
Chan	NULL
,	NULL
1996	NULL
)	NULL
and	NULL
suggest	NULL
that	NULL
the	NULL
binding	NULL
activities	NULL
of	NULL
Pbx-Hox	NULL
complexes	NULL
contribute	NULL
to	NULL
the	NULL
position-specific	NULL
activities	NULL
of	NULL
Hox	NULL
genes	NULL
(	NULL
Chang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

The	NULL
transcriptional	NULL
properties	NULL
of	NULL
Pbx1	NULL
are	NULL
altered	NULL
following	NULL
fusion	NULL
with	NULL
EZ2a	NULL
due	NULL
to	NULL
the	NULL
acquisition	NULL
of	NULL
two	NULL
transcriptional	NULL
activation	NULL
domains	NULL
located	NULL
within	NULL
the	NULL
E2a	NULL
moiety	NULL
(	NULL
Aronheim	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Quong	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

E2a-Pbx1	NULL
is	NULL
a	NULL
potent	NULL
activator	NULL
,	NULL
whereas	NULL
Pbx1	NULL
is	NULL
a	NULL
non-activator	NULL
,	NULL
of	NULL
synthetic	NULL
reporter	NULL
genes	NULL
containing	NULL
Pbx/	NULL
Hox	NULL
consensus	NULL
binding	NULL
sites	NULL
(	NULL
Lebrun	NULL
and	NULL
Cleary	NULL
,	NULL
1994	NULL
;	NULL
Lu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Van	NULL
Dijk	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Due	NULL
to	NULL
loss	NULL
of	NULL
the	NULL
E2a	NULL
basic	NULL
DNA-binding	NULL
region	NULL
but	NULL
retention	NULL
of	NULL
the	NULL
Pbx	NULL
homeodomain	NULL
,	NULL
the	NULL
EZ2a-Pbx1	NULL
chimera	NULL
displays	NULL
DNA-binding	NULL
properties	NULL
identical	NULL
to	NULL
those	NULL
of	NULL
wild	NULL
type	NULL
Pbx	NULL
proteins	NULL
and	NULL
in	NULL
this	NULL
capacity	NULL
binds	NULL
DNA	NULL
cooperatively	NULL
with	NULL
class	NULL
I	NULL
Hox	NULL
proteins	NULL
(	NULL
Chang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
,	NULL
1996	NULL
;	NULL
Lu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Phelan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

These	NULL
features	NULL
support	NULL
an	NULL
hypothesis	NULL
that	NULL
the	NULL
oncogenic	NULL
properties	NULL
of	NULL
EZa-Pbx1	NULL
result	NULL
from	NULL
subversion	NULL
of	NULL
target	NULL
genes	NULL
whose	NULL
expression	NULL
is	NULL
normally	NULL
regulated	NULL
by	NULL
wild	NULL
type	NULL
Pbx	NULL
proteins	NULL
in	NULL
the	NULL
context	NULL
of	NULL
their	NULL
role	NULL
as	NULL
cofactors	NULL
for	NULL
Hox	NULL
and	NULL
non-Hox	NULL
homeodomain	NULL
proteins	NULL
.	NULL

E2Za-Pbx1	NULL
displays	NULL
oncogenic	NULL
activity	NULL
in	NULL
several	NULL
different	NULL
cell	NULL
types	NULL
despite	NULL
its	NULL
restricted	NULL
association	NULL
with	NULL
a	NULL
subset	NULL
of	NULL
human	NULL
leukemias	NULL
.	NULL

Fibroblasts	NULL
,	NULL
myeloblasts	NULL
and	NULL
lymphoblasts	NULL
have	NULL
all	NULL
been	NULL
shown	NULL
experimentally	NULL
to	NULL
undergo	NULL
neoplastic	NULL
change	NULL
in	NULL
response	NULL
to	NULL
forced	NULL
expression	NULL
of	NULL
EZa-Pbx1	NULL
(	NULL
Dedera	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Kamps	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
,	NULL
1993	NULL
,	NULL
1996	NULL
;	NULL
Monica	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

However	NULL
,	NULL
B	NULL
cell	NULL
precursors	NULL
,	NULL
the	NULL
cell	NULL
type	NULL
involved	NULL
in	NULL
human	NULL
t	NULL
(	NULL
1	NULL
;	NULL
19	NULL
)	NULL
leukemias	NULL
,	NULL
are	NULL
curiously	NULL
resistant	NULL
to	NULL
experimental	NULL
transformation	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
precursor	NULL
B	NULL
cells	NULL
in	NULL
vitro	NULL
do	NULL
not	NULL
tolerate	NULL
stable	NULL
expression	NULL
of	NULL
EZa-Pbx1	NULL
(	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

In	NULL
vivo	NULL
,	NULL
expression	NULL
of	NULL
an	NULL
EZa-Pbx1	NULL
transgene	NULL
in	NULL
the	NULL
lymphoid	NULL
compartment	NULL
of	NULL
transgenic	NULL
mice	NULL
resulted	NULL
in	NULL
profound	NULL
hypoplasias	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
hyperplasias	NULL
seen	NULL
with	NULL
other	NULL
oncogenes	NULL
expressed	NULL
under	NULL
similar	NULL
conditions	NULL
.	NULL

In	NULL
spite	NULL
of	NULL
this	NULL
,	NULL
E2a-Pbx1	NULL
mice	NULL
developed	NULL
T	NULL
lineage	NULL
,	NULL
but	NULL
not	NULL
B	NULL
lineage	NULL
,	NULL
lymphoblastic	NULL
lymphomas	NULL
although	NULL
thymuses	NULL
were	NULL
noted	NULL
to	NULL
contain	NULL
markedly	NULL
increased	NULL
numbers	NULL
of	NULL
cells	NULL
undergoing	NULL
apoptosis	NULL
.	NULL

These	NULL
observations	NULL
suggested	NULL
that	NULL
EZa-Pbx1	NULL
may	NULL
modulate	NULL
Apoptsosis	NULL
induced	NULL
in	NULL
vitro	NULL
by	NULL
EZa-Pbx1	NULL
KS	NULL
Smith	NULL
et	NULL
al	NULL
2918	NULL
cell	NULL
survival	NULL
and	NULL
that	NULL
its	NULL
oncogenic	NULL
properties	NULL
may	NULL
depend	NULL
on	NULL
the	NULL
relative	NULL
resistance	NULL
of	NULL
various	NULL
cell	NULL
types	NULL
of	NULL
apoptosis	NULL
.	NULL

Apoptosis	NULL
,	NULL
or	NULL
programmed	NULL
cell	NULL
death	NULL
,	NULL
is	NULL
a	NULL
genetically	NULL
controlled	NULL
process	NULL
(	NULL
Ellis	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
that	NULL
is	NULL
frequently	NULL
subject	NULL
to	NULL
failure	NULL
in	NULL
neoplastic	NULL
cells	NULL
.	NULL

This	NULL
has	NULL
been	NULL
most	NULL
dramatically	NULL
illustrated	NULL
by	NULL
studies	NULL
of	NULL
Bel-2	NULL
and	NULL
related	NULL
family	NULL
members	NULL
(	NULL
reviewed	NULL
in	NULL
Nunez	NULL
and	NULL
Clarke	NULL
,	NULL
1994	NULL
)	NULL
which	NULL
function	NULL
as	NULL
repressors	NULL
or	NULL
inducers	NULL
of	NULL
programmed	NULL
cell	NULL
death	NULL
.	NULL

The	NULL
inter-relationships	NULL
of	NULL
growth	NULL
control	NULL
and	NULL
apoptotic	NULL
pathways	NULL
are	NULL
further	NULL
demonstrated	NULL
by	NULL
studies	NULL
showing	NULL
that	NULL
tumor	NULL
suppressor	NULL
protein	NULL
p53	NULL
induces	NULL
programmed	NULL
cell	NULL
death	NULL
following	NULL
DNA	NULL
damage	NULL
by	NULL
ionizing	NULL
radiation	NULL
(	NULL
Kastan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
or	NULL
certain	NULL
genotoxic	NULL
chemicals	NULL
(	NULL
Lowe	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

The	NULL
role	NULL
of	NULL
p53	NULL
in	NULL
apoptosis	NULL
is	NULL
independent	NULL
of	NULL
its	NULL
ability	NULL
to	NULL
potentiate	NULL
cell	NULL
cycle	NULL
arrest	NULL
through	NULL
induction	NULL
of	NULL
p21	NULL
(	NULL
Wagner	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Recent	NULL
reports	NULL
show	NULL
a	NULL
functional	NULL
role	NULL
for	NULL
p53	NULL
in	NULL
oncogene-mediated	NULL
apoptosis	NULL
(	NULL
Harrington	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Overexpression	NULL
of	NULL
the	NULL
proto-oncogene	NULL
c-myc	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
modulate	NULL
apoptotic	NULL
cell	NULL
death	NULL
in	NULL
rat	NULL
fibroblasts	NULL
under	NULL
low	NULL
serum	NULL
conditions	NULL
or	NULL
drug-induced	NULL
cell	NULL
cycle	NULL
arrest	NULL
(	NULL
Evan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Myc-induced	NULL
apoptosis	NULL
is	NULL
dependent	NULL
on	NULL
p53	NULL
induction	NULL
(	NULL
Hermeking	NULL
and	NULL
Eick	NULL
,	NULL
1994	NULL
)	NULL
and	NULL
may	NULL
represent	NULL
a	NULL
cell-suicide	NULL
response	NULL
to	NULL
inappropriate	NULL
cell	NULL
cycle	NULL
progression	NULL
.	NULL

Likewise	NULL
the	NULL
adenoviral	NULL
oncoprotein	NULL
E1A	NULL
induces	NULL
cell	NULL
cycle	NULL
advancement	NULL
and	NULL
concomitant	NULL
p53-mediated	NULL
apoptosis	NULL
in	NULL
primary	NULL
rodent	NULL
cells	NULL
but	NULL
co-expressed	NULL
EIB	NULL
inhibits	NULL
p53	NULL
with	NULL
resultant	NULL
suppression	NULL
of	NULL
apoptosis	NULL
(	NULL
Debbas	NULL
and	NULL
White	NULL
,	NULL
1993	NULL
)	NULL
.	NULL

In	NULL
this	NULL
report	NULL
we	NULL
show	NULL
that	NULL
conditional	NULL
expression	NULL
of	NULL
the	NULL
nuclear	NULL
oncoprotein	NULL
E2a-Pbx1	NULL
induces	NULL
apoptosis	NULL
in	NULL
hematopoietic	NULL
precursor	NULL
cell	NULL
lines	NULL
in	NULL
vitro	NULL
.	NULL

A	NULL
structure-function	NULL
analysis	NULL
demonstrated	NULL
that	NULL
induction	NULL
of	NULL
apoptosis	NULL
by	NULL
EZa-Pbx1	NULL
requires	NULL
its	NULL
function	NULL
as	NULL
a	NULL
chimeric	NULL
transcription	NULL
factor	NULL
.	NULL

EZ2a-Pbx1-induced	NULL
apoptosis	NULL
proceeds	NULL
through	NULL
a	NULL
BCL2-responsive	NULL
checkpoint	NULL
and	NULL
eventuates	NULL
in	NULL
PARP	NULL
inactivation	NULL
but	NULL
does	NULL
not	NULL
involve	NULL
alterations	NULL
of	NULL
several	NULL
other	NULL
known	NULL
mediators	NULL
of	NULL
apoptosis	NULL
including	NULL
p53	NULL
.	NULL

Furthermore	NULL
,	NULL
unlike	NULL
mye	NULL
,	NULL
EZa-Pbx1l	NULL
does	NULL
not	NULL
induce	NULL
apoptosis	NULL
or	NULL
continued	NULL
cycling	NULL
activity	NULL
of	NULL
Rat-l	NULL
fibroblasts	NULL
in	NULL
low	NULL
serum	NULL
conditions	NULL
.	NULL

These	NULL
data	NULL
demonstrate	NULL
that	NULL
EZa-Pbx1	NULL
initiates	NULL
programmed	NULL
cell	NULL
death	NULL
in	NULL
hematopoietic	NULL
cells	NULL
but	NULL
it	NULL
does	NULL
so	NULL
by	NULL
a	NULL
mechanism	NULL
different	NULL
from	NULL
other	NULL
nuclear	NULL
oncoproteins	NULL
that	NULL
is	NULL
not	NULL
dependent	NULL
on	NULL
p53	NULL
.	NULL

Results	NULL
Conditional	NULL
expression	NULL
of	NULL
E2a-Pbx1	NULL
under	NULL
control	NULL
of	NULL
a	NULL
metal	NULL
response	NULL
element	NULL
in	NULL
the	NULL
Reh	NULL
B-cell	NULL
precursor	NULL
cell	NULL
line	NULL
To	NULL
obtain	NULL
conditional	NULL
expression	NULL
of	NULL
EZa-Pbx1	NULL
in	NULL
B	NULL
cell	NULL
precursors	NULL
,	NULL
the	NULL
EZa-Pbx	NULL
splice	NULL
variant	NULL
1b	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
metal	NULL
response	NULL
element	NULL
vector	NULL
MRE-pNEO	NULL
and	NULL
the	NULL
resulting	NULL
construct	NULL
(	NULL
MRE-E2A-PBX1b	NULL
)	NULL
(	NULL
Figure	NULL
la	NULL
)	NULL
was	NULL
transfected	NULL
by	NULL
electroporation	NULL
into	NULL
Reh	NULL
cells	NULL
.	NULL

Stably	NULL
transfected	NULL
Reh	NULL
cells	NULL
were	NULL
selected	NULL
in	NULL
G-418	NULL
and	NULL
single	NULL
cell	NULL
clones	NULL
were	NULL
isolated	NULL
by	NULL
FACS	NULL
sorting	NULL
or	NULL
limiting	NULL
dilution	NULL
.	NULL

Cells	NULL
(	NULL
MT1	NULL
)	NULL
containing	NULL
the	NULL
empty	NULL
MRE-pNEO	NULL
vector	NULL
were	NULL
also	NULL
selected	NULL
and	NULL
used	NULL
as	NULL
negative	NULL
controls	NULL
in	NULL
all	NULL
subsequent	NULL
experiments	NULL
.	NULL

I	NULL
a	NULL
&	NULL
xA	NULL
p	NULL
q	NULL
?	NULL

4	NULL
L	NULL
$	NULL
Â£	NULL
G	NULL
[	NULL
T	NULL
b	NULL
0	NULL
12	NULL
24	NULL
36	NULL
48	NULL
60	NULL
Hr	NULL
Post-Induction	NULL
MTi	NULL
a	NULL
|	NULL
wees	NULL
|	NULL
onmy	NULL
|	NULL
meg	NULL
s	NULL
cm	NULL
ee	NULL
-	NULL
(	NULL
VT	NULL
E20	NULL
neu	NULL
,	NULL
1	NULL
-o	NULL
come	NULL
``	NULL
notes	NULL
``	NULL
.	NULL

nute	NULL
_	NULL
AZ	NULL
arg	NULL
~~	NULL
wt	NULL
E2a	NULL
Figure	NULL
1	NULL
-	NULL
Conditional	NULL
expression	NULL
of	NULL
EZa-Pbx1b	NULL
under	NULL
control	NULL
of	NULL
a	NULL
metal	NULL
response	NULL
element	NULL
(	NULL
MRE	NULL
)	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Schematic	NULL
illustration	NULL
of	NULL
the	NULL
MRE-E2A-PBX1b	NULL
construct	NULL
used	NULL
for	NULL
stable	NULL
transfection	NULL
of	NULL
the	NULL
B-cell	NULL
precursor	NULL
cell	NULL
line	NULL
Reh	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Time	NULL
course	NULL
of	NULL
EZa-Pbxlb	NULL
induction	NULL
.	NULL

Reh	NULL
pre-B	NULL
cell	NULL
clones	NULL
stably	NULL
transfected	NULL
with	NULL
MRE-E2A-PBX1b	NULL
(	NULL
A2	NULL
)	NULL
or	NULL
MRE	NULL
vector	NULL
without	NULL
insert	NULL
(	NULL
MTI	NULL
)	NULL
were	NULL
treated	NULL
with	NULL
100	NULL
um	NULL
ZnSO	NULL
,	NULL
for	NULL
the	NULL
times	NULL
listed	NULL
above	NULL
the	NULL
gel	NULL
lanes	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
examined	NULL
by	NULL
Western	NULL
blot	NULL
to	NULL
determine	NULL
the	NULL
kinetics	NULL
of	NULL
EZa-Pbxlb	NULL
induction	NULL
.	NULL

EZa-Pbxlb	NULL
was	NULL
detected	NULL
using	NULL
an	NULL
anti-E2a	NULL
monoclonal	NULL
antibody	NULL
(	NULL
Jacobs	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
which	NULL
also	NULL
recognizes	NULL
the	NULL
endogenous	NULL
,	NULL
wild	NULL
type	NULL
EZa	NULL
proteins	NULL
whose	NULL
migrations	NULL
are	NULL
indicated	NULL
to	NULL
the	NULL
right	NULL
Transfected	NULL
Reh	NULL
clones	NULL
were	NULL
screened	NULL
for	NULL
levels	NULL
of	NULL
EZa-Pbxlb	NULL
expression	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
ZnSO	NULL
,	NULL
.	NULL

Several	NULL
clones	NULL
exhibited	NULL
induced	NULL
levels	NULL
of	NULL
EZa-Pbxlb	NULL
equal	NULL
to	NULL
or	NULL
greater	NULL
than	NULL
endogenous	NULL
EZa	NULL
proteins	NULL
E12/E47	NULL
as	NULL
detected	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

The	NULL
results	NULL
obtained	NULL
from	NULL
a	NULL
representative	NULL
clone	NULL
(	NULL
A2	NULL
)	NULL
are	NULL
shown	NULL
in	NULL
Figure	NULL
1b	NULL
.	NULL

Following	NULL
zinc	NULL
exposure	NULL
,	NULL
EZa-Pbxlb	NULL
was	NULL
rapidly	NULL
induced	NULL
in	NULL
the	NULL
A2	NULL
clone	NULL
as	NULL
evidenced	NULL
by	NULL
its	NULL
detection	NULL
as	NULL
early	NULL
as	NULL
2	NULL
h	NULL
post-treatment	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Maximal	NULL
protein	NULL
expression	NULL
was	NULL
observed	NULL
between	NULL
8-12	NULL
h	NULL
post	NULL
induction	NULL
(	NULL
Figure	NULL
1b	NULL
)	NULL
and	NULL
these	NULL
levels	NULL
were	NULL
maintained	NULL
at	NULL
all	NULL
subsequent	NULL
time	NULL
points	NULL
out	NULL
to	NULL
60	NULL
h.	NULL
Prior	NULL
to	NULL
induction	NULL
,	NULL
no	NULL
EZa-Pbxlb	NULL
was	NULL
detected	NULL
in	NULL
A2	NULL
cells	NULL
by	NULL
sensitive	NULL
Western	NULL
blot	NULL
analysis	NULL
indicating	NULL
minimal	NULL
if	NULL
any	NULL
leakiness	NULL
of	NULL
the	NULL
inducible	NULL
MRE	NULL
construct	NULL
.	NULL

The	NULL
antibody	NULL
employed	NULL
for	NULL
Western	NULL
blot	NULL
analysis	NULL
also	NULL
reacted	NULL
with	NULL
endogenous	NULL
wild	NULL
type	NULL
EZa	NULL
proteins	NULL
whose	NULL
levels	NULL
remained	NULL
relatively	NULL
constant	NULL
in	NULL
both	NULL
the	NULL
MTI	NULL
and	NULL
A2	NULL
clones	NULL
throughout	NULL
the	NULL
induction	NULL
period	NULL
.	NULL

E2a-Pbx1b	NULL
induces	NULL
apoptosis	NULL
of	NULL
Reh	NULL
cells	NULL
To	NULL
assess	NULL
the	NULL
effects	NULL
of	NULL
enforced	NULL
EZ2a-Pbx1b	NULL
expression	NULL
on	NULL
precursor	NULL
B	NULL
cells	NULL
,	NULL
the	NULL
MTI	NULL
and	NULL
A2	NULL
clones	NULL
of	NULL
Reh	NULL
were	NULL
treated	NULL
with	NULL
two	NULL
different	NULL
concentrations	NULL
of	NULL
ZnSO	NULL
,	NULL
(	NULL
25	NULL
or	NULL
100	NULL
um	NULL
)	NULL
for	NULL
72	NULL
h.	NULL
At	NULL
specific	NULL
time	NULL
points	NULL
post-induction	NULL
,	NULL
cell	NULL
numbers	NULL
and	NULL
viabilities	NULL
were	NULL
scored	NULL
by	NULL
microscopic	NULL
assessment	NULL
of	NULL
morphologic	NULL
features	NULL
characteristic	NULL
of	NULL
apoptosis	NULL
(	NULL
cytoplasmic	NULL
blebbing	NULL
and	NULL
nuclear	NULL
condensation	NULL
)	NULL
.	NULL

Prior	NULL
to	NULL
ZnSO	NULL
,	NULL
induction	NULL
,	NULL
over	NULL
95	NULL
%	NULL
of	NULL
A2	NULL
cells	NULL
were	NULL
viable	NULL
,	NULL
but	NULL
by	NULL
24	NULL
h	NULL
post-induction	NULL
with	NULL
100	NULL
uM	NULL
ZnSQO	NULL
,	NULL
,	NULL
A2	NULL
viability	NULL
dropped	NULL
to	NULL
80	NULL
%	NULL
and	NULL
continued	NULL
to	NULL
decrease	NULL
to	NULL
approximately	NULL
20	NULL
%	NULL
survival	NULL
by	NULL
72	NULL
h	NULL
(	NULL
Figure	NULL
2a	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
treatment	NULL
of	NULL
the	NULL
A2	NULL
clone	NULL
with	NULL
25	NULL
uM	NULL
ZnSO	NULL
,	NULL
did	NULL
not	NULL
appreciably	NULL
alter	NULL
overall	NULL
cell	NULL
survival	NULL
from	NULL
pretreatment	NULL
levels	NULL
demonstrating	NULL
a	NULL
dosage	NULL
dependent	NULL
response	NULL
of	NULL
A2	NULL
to	NULL
zinc	NULL
treatment	NULL
.	NULL

Neither	NULL
concentration	NULL
of	NULL
ZnSO	NULL
,	NULL
induced	NULL
cell	NULL
death	NULL
in	NULL
the	NULL
MT	NULL
1	NULL
control	NULL
cells	NULL
whose	NULL
survival	NULL
was	NULL
maintained	NULL
at	NULL
greater	NULL
than	NULL
90	NULL
%	NULL
throughout	NULL
the	NULL
72	NULL
h	NULL
treatment	NULL
period	NULL
.	NULL

The	NULL
response	NULL
of	NULL
A2	NULL
cells	NULL
to	NULL
different	NULL
concentrations	NULL
of	NULL
ZnSO	NULL
,	NULL
was	NULL
directly	NULL
related	NULL
to	NULL
the	NULL
induced	NULL
levels	NULL
of	NULL
E2a-Pbx1lb	NULL
protein	NULL
expression	NULL
as	NULL
assessed	NULL
by	NULL
Western	NULL
%	NULL
Cell	NULL
Surv	NULL
Time	NULL
(	NULL
h	NULL
)	NULL
b	NULL
MTI	NULL
A2	NULL
25	NULL
100	NULL
25	NULL
100	NULL
-	NULL
uM	NULL
ZnSO	NULL
,	NULL
%	NULL
-	NULL
E2a-Pbx1b	NULL
cae	NULL
-	NULL
$	NULL
-	NULL
wit	NULL
E2A	NULL
c	NULL
d	NULL
MTI	NULL
A2	NULL
*	NULL
G	NULL
AC	NULL
Â«	NULL
<	NULL
Â«	NULL
Cb	NULL
a	NULL
AC	NULL
sie	NULL
)	NULL
AC	NULL
#	NULL
Figure	NULL
2	NULL
Induction	NULL
of	NULL
apoptosis	NULL
by	NULL
E2a-Pbx1b	NULL
in	NULL
Reh	NULL
cells	NULL
.	NULL

(	NULL
a	NULL
)	NULL
The	NULL
percentage	NULL
of	NULL
surviving	NULL
cells	NULL
was	NULL
assessed	NULL
over	NULL
72	NULL
h	NULL
following	NULL
addition	NULL
of	NULL
ZnSO	NULL
,	NULL
(	NULL
25	NULL
or	NULL
100	NULL
um	NULL
final	NULL
concentration	NULL
)	NULL
to	NULL
the	NULL
culture	NULL
media	NULL
.	NULL

Viable	NULL
cell	NULL
numbers	NULL
at	NULL
each	NULL
time	NULL
point	NULL
were	NULL
determined	NULL
by	NULL
light	NULL
microscopic	NULL
assessment	NULL
of	NULL
morphological	NULL
changes	NULL
characteristic	NULL
of	NULL
apoptosis	NULL
.	NULL

Each	NULL
value	NULL
represents	NULL
the	NULL
mean	NULL
of	NULL
triplicate	NULL
samplings	NULL
from	NULL
duplicate	NULL
experiments	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Western	NULL
blot	NULL
analysis	NULL
showing	NULL
dosage-dependent	NULL
expression	NULL
of	NULL
E2a-Pbx1b	NULL
in	NULL
Reh	NULL
cells	NULL
.	NULL

Stably	NULL
transfected	NULL
cells	NULL
containing	NULL
MRE-E2A-PBX1b	NULL
(	NULL
A2	NULL
)	NULL
or	NULL
MRE	NULL
alone	NULL
(	NULL
MT1	NULL
)	NULL
were	NULL
treated	NULL
for	NULL
72	NULL
h	NULL
with	NULL
either	NULL
25	NULL
or	NULL
100	NULL
um	NULL
ZnSO	NULL
,	NULL
Whole	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
expression	NULL
levels	NULL
of	NULL
wild	NULL
type	NULL
and	NULL
chimeric	NULL
EZa	NULL
proteins	NULL
determined	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
using	NULL
an	NULL
anti-E2a	NULL
antibody	NULL
.	NULL

(	NULL
c	NULL
)	NULL
Oligonucleosomal	NULL
DNA	NULL
degradation	NULL
induced	NULL
by	NULL
EZa-Pbxlb	NULL
.	NULL

The	NULL
MTI	NULL
and	NULL
A2	NULL
clones	NULL
were	NULL
treated	NULL
with	NULL
100	NULL
um	NULL
ZnSO	NULL
,	NULL
for	NULL
36	NULL
h	NULL
and	NULL
chromosomal	NULL
DNA	NULL
was	NULL
isolated	NULL
and	NULL
examined	NULL
by	NULL
ethidium	NULL
bromide-agarose	NULL
gel	NULL
electrophoresis	NULL
.	NULL

(	NULL
d	NULL
)	NULL
Cells	NULL
from	NULL
clone	NULL
A2	NULL
were	NULL
visualized	NULL
by	NULL
bright	NULL
field	NULL
microscopy	NULL
(	NULL
200	NULL
x	NULL
magnification	NULL
)	NULL
following	NULL
72	NULL
h	NULL
of	NULL
100	NULL
um	NULL
zinc	NULL
induction	NULL
.	NULL

Cells	NULL
displaying	NULL
morphologic	NULL
features	NULL
of	NULL
apoptosis	NULL
(	NULL
AC	NULL
)	NULL
are	NULL
indicated	NULL
Apoptsosis	NULL
induced	NULL
in	NULL
vitro	NULL
by	NULL
EZa-Pbx1	NULL
KS	NULL
Smith	NULL
et	NULL
al	NULL
blot	NULL
analysis	NULL
.	NULL

Considerably	NULL
lower	NULL
levels	NULL
of	NULL
EZ2a-Pbx1b	NULL
were	NULL
detected	NULL
at	NULL
25	NULL
uM	NULL
compared	NULL
to	NULL
the	NULL
robust	NULL
expression	NULL
at	NULL
100	NULL
uM	NULL
(	NULL
Figure	NULL
2b	NULL
)	NULL
.	NULL

Neither	NULL
concentration	NULL
had	NULL
an	NULL
appreciable	NULL
effect	NULL
on	NULL
expression	NULL
of	NULL
endogenous	NULL
EZa	NULL
proteins	NULL
in	NULL
the	NULL
MTl	NULL
and	NULL
A2	NULL
clones	NULL
.	NULL

Cell	NULL
death	NULL
induced	NULL
by	NULL
EZa-Pbxlib	NULL
demonstrated	NULL
molecular	NULL
and	NULL
morphologic	NULL
features	NULL
characteristic	NULL
of	NULL
apoptosis	NULL
.	NULL

Ethidium	NULL
bromide-agarose	NULL
gel	NULL
electrophoresis	NULL
of	NULL
chromosomal	NULL
DNA	NULL
isolated	NULL
36	NULL
h	NULL
post-induction	NULL
with	NULL
zinc	NULL
showed	NULL
oligonucleosomal	NULL
DNA	NULL
degradation	NULL
in	NULL
A2	NULL
but	NULL
not	NULL
MTI	NULL
cells	NULL
(	NULL
Figure	NULL
2Â¢	NULL
)	NULL
.	NULL

Bright	NULL
field	NULL
microscopy	NULL
of	NULL
A2	NULL
cells	NULL
showed	NULL
numerous	NULL
cells	NULL
with	NULL
condensed	NULL
chromatin	NULL
,	NULL
severe	NULL
vacuolization	NULL
and	NULL
membrane	NULL
blebbing	NULL
characteristic	NULL
of	NULL
cells	NULL
undergoing	NULL
apoptosis	NULL
in	NULL
vitro	NULL
(	NULL
Figure	NULL
2d	NULL
)	NULL
.	NULL

Induction	NULL
of	NULL
apoptosis	NULL
by	NULL
EZa-Pbx1	NULL
requires	NULL
its	NULL
function	NULL
as	NULL
a	NULL
transcription	NULL
factor	NULL
Previous	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
EZa-Pbx1	NULL
contains	NULL
several	NULL
domains	NULL
that	NULL
are	NULL
necessary	NULL
for	NULL
its	NULL
transcriptional	NULL
and	NULL
oncogenic	NULL
properties	NULL
(	NULL
Chang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Monica	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

To	NULL
assess	NULL
which	NULL
portions	NULL
of	NULL
E2a-Pbx1	NULL
are	NULL
required	NULL
for	NULL
induction	NULL
of	NULL
apoptosis	NULL
,	NULL
we	NULL
performed	NULL
a	NULL
structure/function	NULL
analysis	NULL
that	NULL
utilized	NULL
several	NULL
mutant	NULL
forms	NULL
of	NULL
EZa-Pbx1	NULL
whose	NULL
expression	NULL
was	NULL
regulated	NULL
by	NULL
the	NULL
MRE	NULL
in	NULL
stably	NULL
transfected	NULL
Reh	NULL
cells	NULL
.	NULL

The	NULL
various	NULL
constructs	NULL
employed	NULL
for	NULL
these	NULL
studies	NULL
contained	NULL
deletions	NULL
in	NULL
the	NULL
Pbx	NULL
portion	NULL
of	NULL
the	NULL
chimeric	NULL
protein	NULL
as	NULL
shown	NULL
schematically	NULL
in	NULL
Figure	NULL
3a	NULL
.	NULL

We	NULL
also	NULL
assessed	NULL
the	NULL
properties	NULL
of	NULL
EZ2a-Pbx1la	NULL
,	NULL
an	NULL
isomer	NULL
which	NULL
differs	NULL
at	NULL
its	NULL
carboxy	NULL
terminus	NULL
due	NULL
to	NULL
differential	NULL
splicing	NULL
(	NULL
Nourse	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
to	NULL
assess	NULL
the	NULL
specific	NULL
contribution	NULL
of	NULL
the	NULL
Pbx	NULL
moiety	NULL
versus	NULL
other	NULL
DNA-binding	NULL
motifs	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
apoptotic	NULL
potential	NULL
of	NULL
EZ2a-HIf	NULL
,	NULL
another	NULL
leukemia-associated	NULL
EZa	NULL
chimera	NULL
that	NULL
contains	NULL
a	NULL
basic	NULL
region	NULL
and	NULL
leucine	NULL
zipper	NULL
fused	NULL
to	NULL
E2a	NULL
in	NULL
place	NULL
of	NULL
the	NULL
homeodomain	NULL
protein	NULL
Pbx1	NULL
found	NULL
in	NULL
E2a-Pbx1	NULL
(	NULL
Hunger	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Inaba	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Reh	NULL
clones	NULL
harboring	NULL
the	NULL
various	NULL
mutant	NULL
EZa-Pbx1	NULL
constructs	NULL
and	NULL
were	NULL
tested	NULL
for	NULL
expression	NULL
of	NULL
the	NULL
mutated	NULL
proteins	NULL
prior	NULL
to	NULL
and	NULL
following	NULL
zinc	NULL
induction	NULL
.	NULL

Individual	NULL
clones	NULL
capable	NULL
of	NULL
inducing	NULL
appropriately	NULL
sized	NULL
proteins	NULL
at	NULL
levels	NULL
equal	NULL
to	NULL
or	NULL
greater	NULL
than	NULL
endogenous	NULL
EZa	NULL
proteins	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
(	NULL
Figure	NULL
3b	NULL
)	NULL
were	NULL
employed	NULL
for	NULL
further	NULL
studies	NULL
.	NULL

The	NULL
apoptotic	NULL
potentials	NULL
of	NULL
the	NULL
various	NULL
E2a	NULL
chimeras	NULL
were	NULL
determined	NULL
by	NULL
morphologic	NULL
assessments	NULL
of	NULL
cell	NULL
survival	NULL
after	NULL
72	NULL
h	NULL
of	NULL
induction	NULL
with	NULL
100	NULL
uM	NULL
ZnSO	NULL
,	NULL
(	NULL
Figure	NULL
3a	NULL
)	NULL
.	NULL

Both	NULL
isomers	NULL
(	NULL
a	NULL
and	NULL
b	NULL
)	NULL
of	NULL
EZ2a-Pbx1	NULL
were	NULL
capable	NULL
of	NULL
inducing	NULL
apoptosis	NULL
under	NULL
these	NULL
conditions	NULL
although	NULL
EZa-Pbxlb	NULL
was	NULL
slightly	NULL
more	NULL
potent	NULL
than	NULL
E2a-Pbxla	NULL
.	NULL

A	NULL
mutant	NULL
(	NULL
APbx1	NULL
)	NULL
lacking	NULL
all	NULL
Pbx-derived	NULL
sequences	NULL
and	NULL
consisting	NULL
solely	NULL
of	NULL
the	NULL
EZ2a	NULL
portion	NULL
of	NULL
the	NULL
chimera	NULL
was	NULL
incapable	NULL
of	NULL
inducing	NULL
apoptosis	NULL
indicating	NULL
a	NULL
need	NULL
for	NULL
specific	NULL
motifs	NULL
from	NULL
Pbx1	NULL
.	NULL

The	NULL
required	NULL
Pbx	NULL
sequences	NULL
appeared	NULL
to	NULL
consist	NULL
of	NULL
more	NULL
than	NULL
its	NULL
homeodomain	NULL
since	NULL
a	NULL
mutant	NULL
(	NULL
HD	NULL
Â»	NULL
;	NULL
-	NULL
Â»	NULL
)	NULL
containing	NULL
the	NULL
Pbx	NULL
homeodomain	NULL
fused	NULL
directly	NULL
to	NULL
EZa	NULL
was	NULL
incapable	NULL
of	NULL
inducing	NULL
apoptosis	NULL
.	NULL

However	NULL
,	NULL
inclusion	NULL
of	NULL
12	NULL
additional	NULL
amino	NULL
acids	NULL
flanking	NULL
the	NULL
carboxy	NULL
end	NULL
of	NULL
the	NULL
homeodomain	NULL
(	NULL
construct	NULL
HD	NULL
Â»	NULL
Â»	NULL
-s1	NULL
,	NULL
)	NULL
restored	NULL
apopototic	NULL
properties	NULL
to	NULL
the	NULL
chimera	NULL
(	NULL
50	NULL
%	NULL
of	NULL
EZa-Pbxlb	NULL
activity	NULL
)	NULL
.	NULL

These	NULL
data	NULL
define	NULL
a	NULL
minimal	NULL
portion	NULL
of	NULL
Pbx1	NULL
that	NULL
is	NULL
functionally	NULL
competent	NULL
for	NULL
induction	NULL
of	NULL
apoptosis	NULL
and	NULL
are	NULL
consistent	NULL
with	NULL
previous	NULL
2919	NULL
Apoptsosis	NULL
induced	NULL
in	NULL
vitro	NULL
by	NULL
EZa-Pbx1	NULL
KS	NULL
Smith	NULL
et	NULL
al	NULL
2920	NULL
studies	NULL
of	NULL
ours	NULL
showing	NULL
that	NULL
the	NULL
comparable	NULL
portions	NULL
of	NULL
Pbx	NULL
are	NULL
required	NULL
for	NULL
cooperative	NULL
DNA-binding	NULL
in	NULL
vitro	NULL
with	NULL
Hox	NULL
proteins	NULL
(	NULL
Chang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

The	NULL
required	NULL
sequences	NULL
flanking	NULL
the	NULL
Pbx	NULL
homeodomain	NULL
have	NULL
been	NULL
proposed	NULL
to	NULL
mediate	NULL
heterologous	NULL
interactions	NULL
with	NULL
Hox	NULL
proteins	NULL
(	NULL
Chang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Two	NULL
additional	NULL
constructs	NULL
(	NULL
1IbAHD	NULL
and	NULL
A232-430	NULL
)	NULL
coding	NULL
for	NULL
mutants	NULL
that	NULL
lack	NULL
the	NULL
Pbx	NULL
homeodomain	NULL
were	NULL
incapable	NULL
of	NULL
inducing	NULL
apoptosis	NULL
providing	NULL
further	NULL
evidence	NULL
that	NULL
the	NULL
EZa-Pbx1	NULL
chimera	NULL
needs	NULL
to	NULL
bind	NULL
DNA	NULL
through	NULL
its	NULL
homeodomain	NULL
to	NULL
induce	NULL
apoptosis	NULL
under	NULL
these	NULL
experimental	NULL
conditions	NULL
.	NULL

A	NULL
mutant	NULL
(	NULL
A299	NULL
308	NULL
)	NULL
with	NULL
partial	NULL
deletion	NULL
of	NULL
the	NULL
Hox	NULL
cooperativity	NULL
motif	NULL
(	NULL
Chang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
was	NULL
severely	NULL
compromised	NULL
in	NULL
its	NULL
apoptotic	NULL
properties	NULL
but	NULL
still	NULL
able	NULL
to	NULL
adversely	NULL
affect	NULL
viability	NULL
(	NULL
45	NULL
%	NULL
of	NULL
EZa-Pbxlb	NULL
activity	NULL
)	NULL
.	NULL

No	NULL
apoptosis	NULL
was	NULL
observed	NULL
following	NULL
induction	NULL
of	NULL
EZa-HIf	NULL
expression	NULL
suggesting	NULL
that	NULL
specific	NULL
recognition	NULL
of	NULL
Pbx	NULL
but	NULL
not	NULL
HIf	NULL
targets	NULL
renders	NULL
Reh	NULL
cells	NULL
susceptible	NULL
to	NULL
apoptosis	NULL
.	NULL

Effects	NULL
of	NULL
EZ2a-Pbx1	NULL
on	NULL
known	NULL
modulators	NULL
of	NULL
apoptosis	NULL
To	NULL
investigate	NULL
potential	NULL
mechanisms	NULL
by	NULL
which	NULL
EZ2a-Pbx1	NULL
induces	NULL
apoptosis	NULL
,	NULL
we	NULL
assessed	NULL
the	NULL
expression	NULL
a	NULL
Relative	NULL
spoptomy	NULL
actmity	NULL
(	NULL
#	NULL
)	NULL
g	NULL
m	NULL
Â«	NULL
0	NULL
oo	NULL
so	NULL
10	NULL
Pol-	NULL
1	NULL
4	NULL
cn	NULL
fmt	NULL
=	NULL
P	NULL
D	NULL
gel	NULL
1	NULL
f	NULL
n	NULL
T	NULL
-V	NULL
â	NULL
7	NULL
â	NULL
tamed	NULL
~	NULL
~O	NULL
%	NULL
MÂ©	NULL
]	NULL
2so30e	NULL
C	NULL
--	NULL
,	NULL
0840	NULL
tewo	NULL
-	NULL
C227	NULL
39	NULL
O	NULL
ma	NULL
Â»	NULL
``	NULL
O	NULL
}	NULL
|	NULL
omnrne	NULL
-	NULL
Â®	NULL
rors	NULL
___	NULL
2	NULL
L.	NULL
w	NULL
Cmc	NULL
tram	NULL
:	NULL
-	NULL
_	NULL
MT	NULL
!	NULL

Vector	NULL
Bassline	NULL
b	NULL
a	NULL
&	NULL
o	NULL
Â©	NULL
~	NULL
-	NULL
o	NULL
z	NULL
Â®	NULL
x	NULL
x	NULL
g	NULL
;	NULL
a	NULL
n	NULL
o	NULL
+	NULL
a	NULL
a	NULL
To	NULL
m	NULL
Mo	NULL
e	NULL
z	NULL
O	NULL
4	NULL
&	NULL
m	NULL
A	NULL
M	NULL
M	NULL
x	NULL
+	NULL
T	NULL
p	NULL
g	NULL
C4	NULL
~	NULL
om	NULL
m	NULL
+	NULL
=	NULL
&	NULL
a	NULL
Â®	NULL
2	NULL
a	NULL
4	NULL
Â«	NULL
nm	NULL
o	NULL
o	NULL
0	NULL
0	NULL
a	NULL
~s	NULL
w	NULL
w	NULL
<	NULL
G	NULL
G	NULL
I	NULL
I	NULL
4	NULL
w	NULL
Â«	NULL
J	NULL
-	NULL
@	NULL
Â»	NULL
Figure	NULL
3	NULL
Structural	NULL
requirements	NULL
of	NULL
E2a-Pbx1	NULL
for	NULL
induction	NULL
of	NULL
apoptosis	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Schematic	NULL
illustrations	NULL
are	NULL
shown	NULL
of	NULL
the	NULL
various	NULL
intact	NULL
and	NULL
mutant	NULL
EZa-Pbx1	NULL
proteins	NULL
expressed	NULL
under	NULL
control	NULL
of	NULL
the	NULL
MRE	NULL
in	NULL
Reh	NULL
cells	NULL
.	NULL

Deleted	NULL
regions	NULL
of	NULL
mutant	NULL
constructs	NULL
are	NULL
depicted	NULL
by	NULL
blanks	NULL
.	NULL

Also	NULL
shown	NULL
is	NULL
the	NULL
chimeric	NULL
bZIP	NULL
protein	NULL
EZa-HIf	NULL
.	NULL

Cross-hatched	NULL
boxes	NULL
denote	NULL
the	NULL
Pbx1	NULL
homeodomain	NULL
or	NULL
Hif	NULL
bZIP	NULL
motifs	NULL
.	NULL

Results	NULL
of	NULL
apoptosis	NULL
assays	NULL
for	NULL
each	NULL
construct	NULL
are	NULL
expressed	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
apoptotic	NULL
activity	NULL
relative	NULL
to	NULL
intact	NULL
E2Za-Pbx1b	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
surviving	NULL
cells	NULL
was	NULL
assessed	NULL
over	NULL
72	NULL
h	NULL
following	NULL
addition	NULL
of	NULL
ZnSO	NULL
,	NULL
(	NULL
100	NULL
um	NULL
final	NULL
concentration	NULL
)	NULL
to	NULL
the	NULL
culture	NULL
media	NULL
.	NULL

Viable	NULL
cell	NULL
numbers	NULL
at	NULL
each	NULL
time	NULL
point	NULL
were	NULL
determined	NULL
by	NULL
light	NULL
microscopic	NULL
assessment	NULL
of	NULL
morphological	NULL
changes	NULL
characteristic	NULL
of	NULL
apoptosis	NULL
.	NULL

Each	NULL
value	NULL
represents	NULL
the	NULL
mean	NULL
of	NULL
triplicate	NULL
samplings	NULL
from	NULL
duplicate	NULL
experiments	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Clonal	NULL
populations	NULL
of	NULL
Reh	NULL
cells	NULL
stably	NULL
transfected	NULL
with	NULL
intact	NULL
or	NULL
mutant	NULL
E2a-Pbx1	NULL
constructs	NULL
under	NULL
control	NULL
of	NULL
an	NULL
MRE	NULL
were	NULL
induced	NULL
with	NULL
100	NULL
um	NULL
ZnSO	NULL
,	NULL
for	NULL
12	NULL
h	NULL
and	NULL
cell	NULL
lysates	NULL
from	NULL
each	NULL
were	NULL
used	NULL
for	NULL
Western	NULL
blot	NULL
analysis	NULL
using	NULL
an	NULL
anti-E2a	NULL
monoclonal	NULL
antibody	NULL
.	NULL

The	NULL
M	NULL
;	NULL
of	NULL
each	NULL
was	NULL
assessed	NULL
using	NULL
prestained	NULL
protein	NULL
standards	NULL
patterns	NULL
of	NULL
various	NULL
proteins	NULL
known	NULL
to	NULL
be	NULL
modulators	NULL
of	NULL
apoptosis	NULL
using	NULL
Western	NULL
blot	NULL
analysis	NULL
following	NULL
100	NULL
uM	NULL
zinc	NULL
induction	NULL
of	NULL
A2	NULL
and	NULL
MTI	NULL
cells	NULL
.	NULL

Immunodetection	NULL
of	NULL
Bcel-2	NULL
,	NULL
a	NULL
known	NULL
repressor	NULL
of	NULL
programmed	NULL
cell	NULL
death	NULL
,	NULL
showed	NULL
that	NULL
its	NULL
levels	NULL
decreased	NULL
in	NULL
A2	NULL
but	NULL
not	NULL
MT1	NULL
cells	NULL
(	NULL
Figure	NULL
4	NULL
)	NULL
,	NULL
however	NULL
this	NULL
decrease	NULL
occurred	NULL
late	NULL
after	NULL
48	NULL
h	NULL
of	NULL
induction	NULL
suggesting	NULL
that	NULL
it	NULL
was	NULL
not	NULL
a	NULL
primary	NULL
cause	NULL
of	NULL
apoptosis	NULL
in	NULL
A2	NULL
cells	NULL
We	NULL
also	NULL
assessed	NULL
the	NULL
expression	NULL
levels	NULL
of	NULL
Bcel-2	NULL
superfamily	NULL
members	NULL
Mcl-1	NULL
,	NULL
a	NULL
repressor	NULL
of	NULL
cell	NULL
death	NULL
,	NULL
and	NULL
Bax	NULL
,	NULL
a	NULL
death	NULL
promoter	NULL
,	NULL
by	NULL
Western	NULL
blot	NULL
using	NULL
immune	NULL
sera	NULL
specific	NULL
for	NULL
these	NULL
proteins	NULL
.	NULL

Both	NULL
were	NULL
unaffected	NULL
over	NULL
the	NULL
60	NULL
h	NULL
period	NULL
during	NULL
which	NULL
A2	NULL
cells	NULL
were	NULL
undergoing	NULL
EZa-Pbxl-induced	NULL
apoptosis	NULL
(	NULL
Figure	NULL
4	NULL
)	NULL
.	NULL

We	NULL
also	NULL
quantitated	NULL
the	NULL
levels	NULL
of	NULL
tumor	NULL
suppressor	NULL
gene	NULL
product	NULL
p53	NULL
given	NULL
its	NULL
previously	NULL
reported	NULL
role	NULL
in	NULL
programmed	NULL
cell	NULL
death	NULL
induced	NULL
by	NULL
nuclear	NULL
oncoproteins	NULL
adenovirus	NULL
Ela	NULL
and	NULL
Myc	NULL
(	NULL
Debbas	NULL
and	NULL
White	NULL
,	NULL
1993	NULL
;	NULL
Hermeking	NULL
and	NULL
Eick	NULL
,	NULL
1994	NULL
)	NULL
.	NULL

The	NULL
levels	NULL
of	NULL
p53	NULL
protein	NULL
were	NULL
found	NULL
to	NULL
increase	NULL
dramatically	NULL
in	NULL
A2	NULL
cells	NULL
undergoing	NULL
EZa-Pbxl-induced	NULL
apoptosis	NULL
,	NULL
however	NULL
,	NULL
a	NULL
comparable	NULL
increase	NULL
of	NULL
p53	NULL
was	NULL
observed	NULL
in	NULL
MTl	NULL
cells	NULL
(	NULL
Figure	NULL
4	NULL
)	NULL
which	NULL
lack	NULL
EZa-Pbx1	NULL
and	NULL
do	NULL
not	NULL
undergo	NULL
apoptosis	NULL
suggesting	NULL
that	NULL
p53	NULL
levels	NULL
were	NULL
responding	NULL
to	NULL
the	NULL
zinc	NULL
treatment	NULL
alone	NULL
although	NULL
no	NULL
apparent	NULL
effects	NULL
on	NULL
the	NULL
cycling	NULL
activity	NULL
of	NULL
MTI	NULL
cells	NULL
were	NULL
observed	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
determined	NULL
whether	NULL
PARP	NULL
expression	NULL
and	NULL
composition	NULL
were	NULL
affected	NULL
by	NULL
induction	NULL
of	NULL
apoptosis	NULL
by	NULL
EZa-Pbxlb	NULL
.	NULL

PARP	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
play	NULL
a	NULL
role	NULL
as	NULL
a	NULL
distal	NULL
downstream	NULL
mediator	NULL
in	NULL
0	NULL
12	NULL
24	NULL
36	NULL
48	NULL
60	NULL
Hr	NULL
Post-Induction	NULL
MT	NULL
]	NULL
Â«	NULL
=-	NULL
cam	NULL
Â»	NULL
cam	NULL
cme	NULL
coms	NULL
came	NULL
.	NULL

26	NULL
kD	NULL
BCL-2	NULL
AQ	NULL
=	NULL
wets	NULL
@	NULL
CH	NULL
Cie	NULL
cms	NULL
______________________	NULL
ie	NULL
21	NULL
kD	NULL
Bax	NULL
a	NULL
>	NULL
|-MT	NULL
]	NULL
--	NULL
-	NULL
same	NULL
ames	NULL
dome	NULL
samt	NULL
m	NULL
p	NULL
40	NULL
kD	NULL
Mcl-1	NULL
AQ	NULL
=	NULL
wens	NULL
cum	NULL
coas	NULL
quae	NULL
smae	NULL
o	NULL
Â«	NULL
_	NULL
.	NULL

MTI	NULL
tomes	NULL
.	NULL

gee	NULL
omen	NULL
.	NULL

<	NULL
one	NULL
-	NULL
cmt	NULL
_	NULL
A2	NULL
MTI	NULL
|	NULL
wass	NULL
jusee	NULL
goes	NULL
wee	NULL
Â«	NULL
mn	NULL
116	NULL
kD	NULL
PARP	NULL
ss	NULL
ges	NULL
yor	NULL
mas	NULL
om	NULL
0	NULL
-	NULL
116	NULL
kD	NULL
papp	NULL
A2	NULL
wur	NULL
-	NULL
Tae	NULL
wast	NULL
85	NULL
kD	NULL
PARF	NULL
Figure	NULL
4	NULL
Effects	NULL
of	NULL
EZa-Pbxlb	NULL
on	NULL
known	NULL
modulators	NULL
of	NULL
apoptosis	NULL
.	NULL

Cells	NULL
from	NULL
Reh	NULL
clones	NULL
MTI	NULL
and	NULL
A2	NULL
were	NULL
exposed	NULL
to	NULL
ZnSO	NULL
,	NULL
for	NULL
time	NULL
periods	NULL
indicated	NULL
above	NULL
the	NULL
gel	NULL
lanes	NULL
.	NULL

Aliquots	NULL
were	NULL
examined	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
using	NULL
antibodies	NULL
specific	NULL
for	NULL
various	NULL
modulators	NULL
or	NULL
effectors	NULL
of	NULL
apoptosis	NULL
as	NULL
indicated	NULL
to	NULL
the	NULL
right	NULL
of	NULL
the	NULL
panels	NULL
.	NULL

Immunological	NULL
reagents	NULL
for	NULL
the	NULL
detection	NULL
of	NULL
Bcl-2	NULL
,	NULL
Bax	NULL
,	NULL
Mcl-1	NULL
,	NULL
p53	NULL
and	NULL
PARP	NULL
are	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
methods	NULL
.	NULL

The	NULL
total	NULL
cellular	NULL
protein	NULL
loaded	NULL
per	NULL
gel	NULL
lane	NULL
was	NULL
equalized	NULL
based	NULL
on	NULL
determinations	NULL
,	NULL
.	NULL

Molecular	NULL
weights	NULL
were	NULL
calculated	NULL
based	NULL
on	NULL
co-electrophoresis	NULL
of	NULL
standard	NULL
size	NULL
apoptosis	NULL
,	NULL
namely	NULL
inactivation	NULL
of	NULL
PARP	NULL
by	NULL
proteolytic	NULL
cleavage	NULL
precedes	NULL
chromatin	NULL
degradation	NULL
(	NULL
Kaufmann	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Using	NULL
an	NULL
anti-PARP	NULL
monoclonal	NULL
antibody	NULL
we	NULL
observed	NULL
cleavage	NULL
of	NULL
PARP	NULL
from	NULL
a	NULL
native	NULL
molecular	NULL
weight	NULL
of	NULL
116	NULL
kD	NULL
to	NULL
85	NULL
kD	NULL
over	NULL
the	NULL
60	NULL
h	NULL
timecourse	NULL
(	NULL
Figure	NULL
4	NULL
)	NULL
.	NULL

In	NULL
A2	NULL
cells	NULL
,	NULL
PARP	NULL
cleavage	NULL
was	NULL
first	NULL
detected	NULL
at	NULL
36	NULL
h	NULL
post-induction	NULL
with	NULL
almost	NULL
complete	NULL
cleavage	NULL
to	NULL
the	NULL
85	NULL
kD	NULL
form	NULL
by	NULL
60	NULL
h.	NULL
In	NULL
contrast	NULL
,	NULL
the	NULL
levels	NULL
and	NULL
size	NULL
of	NULL
PARP	NULL
remained	NULL
essentially	NULL
unaltered	NULL
in	NULL
control	NULL
MTI	NULL
cells	NULL
following	NULL
identical	NULL
treatment	NULL
with	NULL
zinc	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
apoptosis	NULL
induced	NULL
by	NULL
EZa-Pbx1	NULL
traverse	NULL
a	NULL
molecular	NULL
pathway	NULL
involving	NULL
activation	NULL
of	NULL
a	NULL
CED-3/ICE	NULL
family	NULL
protease	NULL
which	NULL
responds	NULL
by	NULL
proteolytically	NULL
cleaving	NULL
PARP	NULL
.	NULL

Bel-2	NULL
protects	NULL
against	NULL
EZa-PbxI-induced	NULL
apoptosis	NULL
Given	NULL
the	NULL
known	NULL
role	NULL
of	NULL
Bcel-2	NULL
in	NULL
modulating	NULL
the	NULL
survival	NULL
of	NULL
progenitor	NULL
B	NULL
cells	NULL
,	NULL
the	NULL
delayed	NULL
reduction	NULL
in	NULL
Bcl-2	NULL
levels	NULL
following	NULL
enforced	NULL
expression	NULL
of	NULL
EZa-Pbx1	NULL
in	NULL
Reh	NULL
cells	NULL
suggested	NULL
that	NULL
Bcl-2	NULL
loss	NULL
may	NULL
partially	NULL
contribute	NULL
to	NULL
the	NULL
observed	NULL
cell	NULL
death	NULL
.	NULL

To	NULL
further	NULL
investigate	NULL
the	NULL
effects	NULL
of	NULL
Bcel-2	NULL
on	NULL
EZ2a-Pbxl-induced	NULL
apoptosis	NULL
,	NULL
Bel-2	NULL
was	NULL
constitutively	NULL
expressed	NULL
at	NULL
high	NULL
levels	NULL
under	NULL
control	NULL
of	NULL
the	NULL
CMV	NULL
promoter	NULL
in	NULL
MTl	NULL
and	NULL
A2	NULL
cells	NULL
.	NULL

The	NULL
resulting	NULL
MTI-BCL2	NULL
and	NULL
A2-BCL2	NULL
cells	NULL
were	NULL
then	NULL
treated	NULL
with	NULL
zinc	NULL
and	NULL
assessed	NULL
for	NULL
apoptosis	NULL
.	NULL

A2-BCL2	NULL
cells	NULL
were	NULL
significantly	NULL
protected	NULL
from	NULL
cell	NULL
%	NULL
Cell	NULL
Survival	NULL
+	NULL
T	NULL
T	NULL
Time	NULL
(	NULL
H	NULL
)	NULL
0	NULL
12	NULL
24	NULL
36	NULL
48	NULL
60	NULL
Hr	NULL
Post-Induction	NULL
wus	NULL
suse	NULL
snomeg	NULL
|	NULL
aces	NULL
-	NULL
EZa-Pbx1b	NULL
A2	NULL
an	NULL
a-	NULL
dos	NULL
do	NULL
an	NULL
4D	NULL
-CC\|	NULL
>	NULL
Figure	NULL
5	NULL
BCL-2	NULL
protects	NULL
against	NULL
EZa-Pbxl-induced	NULL
apoptosis	NULL
.	NULL

(	NULL
a	NULL
)	NULL
The	NULL
Reh	NULL
clones	NULL
MTI	NULL
and	NULL
A2	NULL
were	NULL
stably	NULL
transfected	NULL
with	NULL
a	NULL
construct	NULL
that	NULL
constitutively	NULL
expresses	NULL
BCL2	NULL
under	NULL
control	NULL
of	NULL
the	NULL
CMV	NULL
promoter	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
analysed	NULL
by	NULL
Western	NULL
blot	NULL
using	NULL
an	NULL
anti-BLC-2	NULL
monoclonal	NULL
antibody	NULL
.	NULL

(	NULL
b	NULL
)	NULL
The	NULL
resulting	NULL
clones	NULL
(	NULL
MTI-BCL2	NULL
and	NULL
A2-BCL2	NULL
)	NULL
were	NULL
exposed	NULL
to	NULL
100	NULL
um	NULL
ZnSQ4	NULL
over	NULL
the	NULL
course	NULL
of	NULL
72	NULL
h.	NULL
Apoptotic	NULL
cells	NULL
were	NULL
quantitated	NULL
by	NULL
morphological	NULL
assessments	NULL
of	NULL
cell	NULL
viability	NULL
and	NULL
values	NULL
are	NULL
the	NULL
average	NULL
of	NULL
triplicate	NULL
determinations	NULL
Apoptsosis	NULL
induced	NULL
in	NULL
vitro	NULL
by	NULL
EZa-Pbx1	NULL
KS	NULL
Smith	NULL
et	NULL
al	NULL
death	NULL
induced	NULL
by	NULL
E2a-Pbx1	NULL
,	NULL
displaying	NULL
80	NULL
%	NULL
survival	NULL
at	NULL
72	NULL
h	NULL
post-induction	NULL
compared	NULL
to	NULL
20	NULL
%	NULL
survival	NULL
of	NULL
A2	NULL
cells	NULL
(	NULL
Figure	NULL
5	NULL
)	NULL
.	NULL

MTI-BCL2	NULL
cells	NULL
showed	NULL
slightly	NULL
enhanced	NULL
survival	NULL
compared	NULL
to	NULL
MTI	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
zinc	NULL
.	NULL

Thus	NULL
,	NULL
although	NULL
A2	NULL
cells	NULL
express	NULL
detectable	NULL
levels	NULL
of	NULL
endogenous	NULL
Bcl-2	NULL
,	NULL
hyperexpression	NULL
of	NULL
exogenous	NULL
Bcl-2	NULL
confers	NULL
enhanced	NULL
survival	NULL
following	NULL
enforced	NULL
expression	NULL
of	NULL
EZa-Pbx1	NULL
perhaps	NULL
by	NULL
further	NULL
neutralizing	NULL
Bax	NULL
,	NULL
which	NULL
is	NULL
also	NULL
expressed	NULL
in	NULL
Reh	NULL
cells	NULL
(	NULL
Figure	NULL
4	NULL
)	NULL
.	NULL

Our	NULL
studies	NULL
indicate	NULL
that	NULL
the	NULL
apoptotic	NULL
signals	NULL
initiated	NULL
by	NULL
EZa-Pbx1	NULL
proceed	NULL
through	NULL
a	NULL
checkpoint	NULL
that	NULL
is	NULL
responsive	NULL
to	NULL
Bcl-2	NULL
and	NULL
suggest	NULL
a	NULL
mechanism	NULL
by	NULL
which	NULL
lymphoid	NULL
cells	NULL
expressing	NULL
EZa-Pbx1	NULL
following	NULL
chromosomal	NULL
translocations	NULL
may	NULL
escape	NULL
its	NULL
apoptotic	NULL
properties	NULL
and	NULL
contribute	NULL
to	NULL
leukemic	NULL
development	NULL
.	NULL

E2a-Pbx1-induced	NULL
apoptosis	NULL
does	NULL
not	NULL
require	NULL
p53	NULL
An	NULL
essential	NULL
role	NULL
has	NULL
been	NULL
demonstrated	NULL
for	NULL
p53	NULL
in	NULL
mediating	NULL
apoptosis	NULL
induced	NULL
by	NULL
nuclear	NULL
oncoproteins	NULL
Myc	NULL
and	NULL
EIA	NULL
.	NULL

Our	NULL
studies	NULL
described	NULL
above	NULL
of	NULL
apoptosis	NULL
induced	NULL
by	NULL
EZa-Pbx1	NULL
in	NULL
the	NULL
A2	NULL
clone	NULL
of	NULL
Reh	NULL
cells	NULL
showed	NULL
that	NULL
p53	NULL
expression	NULL
is	NULL
markedly	NULL
increased	NULL
following	NULL
EZ2a-Pbx1	NULL
expression	NULL
,	NULL
but	NULL
a	NULL
similar	NULL
increase	NULL
in	NULL
p53	NULL
protein	NULL
levels	NULL
was	NULL
observed	NULL
in	NULL
MTI	NULL
cells	NULL
which	NULL
do	NULL
not	NULL
express	NULL
EZa-Pbx1	NULL
,	NULL
therefore	NULL
a	NULL
specific	NULL
role	NULL
for	NULL
p53	NULL
could	NULL
not	NULL
be	NULL
established	NULL
.	NULL

To	NULL
further	NULL
investigate	NULL
a	NULL
possible	NULL
role	NULL
for	NULL
p53	NULL
,	NULL
we	NULL
assessed	NULL
the	NULL
ability	NULL
of	NULL
EZa-Pbx1	NULL
to	NULL
induce	NULL
apoptosis	NULL
in	NULL
HL60	NULL
cells	NULL
which	NULL
lack	NULL
functional	NULL
p53	NULL
(	NULL
Wolf	NULL
and	NULL
Rotter	NULL
,	NULL
1985	NULL
)	NULL
.	NULL

HL60	NULL
cells	NULL
were	NULL
stably	NULL
transfected	NULL
with	NULL
MRE	NULL
or	NULL
MRE-EZA-PBX1b	NULL
constructs	NULL
,	NULL
cloned	NULL
and	NULL
then	NULL
used	NULL
in	NULL
quantitative	NULL
apoptosis	NULL
assays	NULL
.	NULL

Following	NULL
induction	NULL
of	NULL
EZa-Pbxlb	NULL
expression	NULL
,	NULL
survival	NULL
of	NULL
HL60-E2A-PBX1	NULL
cells	NULL
decreased	NULL
to	NULL
approximately	NULL
40	NULL
%	NULL
at	NULL
72	NULL
h	NULL
compared	NULL
to	NULL
greater	NULL
than	NULL
90	NULL
%	NULL
survival	NULL
for	NULL
HL60	NULL
HL	NULL
GO-MRL	NULL
C	NULL
&	NULL
o	NULL
â¬	NULL
A	NULL
pA	NULL
&	NULL
Â«	NULL
0	NULL
g	NULL
LBO	NULL
2a	NULL
Por	NULL
lt	NULL
ro	NULL
~	NULL
mag	NULL
ZEZJ-F	NULL
â	NULL
L	NULL
â	NULL
ï¬b	NULL
+	NULL
re	NULL
wt	NULL
E2a	NULL
o	NULL
74	NULL
a8	NULL
Time	NULL
(	NULL
h	NULL
)	NULL
Figure	NULL
6	NULL
Induction	NULL
of	NULL
apoptosis	NULL
by	NULL
EZa-Pbx1	NULL
in	NULL
p53-null	NULL
HL60	NULL
cells	NULL
.	NULL

Cell	NULL
viabilities	NULL
were	NULL
determined	NULL
over	NULL
the	NULL
course	NULL
of	NULL
72	NULL
h	NULL
following	NULL
exposure	NULL
to	NULL
100	NULL
um	NULL
ZnSQ4	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
surviving	NULL
HL60-EZa-Pbx1	NULL
and	NULL
control	NULL
HL60-MRE	NULL
cells	NULL
were	NULL
determined	NULL
by	NULL
morphologic	NULL
assessments	NULL
of	NULL
cell	NULL
viability	NULL
.	NULL

Values	NULL
are	NULL
the	NULL
averages	NULL
of	NULL
triplicate	NULL
determinations	NULL
.	NULL

Inset	NULL
shows	NULL
inducible	NULL
expression	NULL
of	NULL
EZa-Pbxlb	NULL
in	NULL
HL60	NULL
cells	NULL
.	NULL

HL60-E2a-Pbx1b	NULL
cells	NULL
stably	NULL
transfected	NULL
with	NULL
MRE-E2A-PBX1B	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
100	NULL
um	NULL
ZnSO	NULL
,	NULL
for	NULL
36	NULL
h.	NULL
Total	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
analysed	NULL
by	NULL
Western	NULL
blot	NULL
using	NULL
an	NULL
anti-EZa	NULL
2921	NULL
Apoptsosis	NULL
induced	NULL
in	NULL
vitro	NULL
by	NULL
EZa-Pbx1	NULL
KS	NULL
Smith	NULL
et	NULL
al	NULL
2922	NULL
MRE	NULL
cells	NULL
(	NULL
Figure	NULL
6	NULL
)	NULL
.	NULL

These	NULL
data	NULL
show	NULL
that	NULL
myeloid	NULL
precursor	NULL
cells	NULL
as	NULL
well	NULL
as	NULL
cells	NULL
of	NULL
the	NULL
lymphoid	NULL
lineage	NULL
are	NULL
susceptible	NULL
to	NULL
the	NULL
apoptotic	NULL
effects	NULL
of	NULL
EZ2a-Pbx1	NULL
and	NULL
that	NULL
p53	NULL
is	NULL
not	NULL
required	NULL
for	NULL
apoptosis	NULL
to	NULL
occur	NULL
under	NULL
these	NULL
experimental	NULL
conditions	NULL
.	NULL

Constitutive	NULL
expression	NULL
of	NULL
EZ2a-Pbx1	NULL
does	NULL
not	NULL
induce	NULL
apoptosis	NULL
or	NULL
continued	NULL
cycling	NULL
of	NULL
Rat-1	NULL
fibroblasts	NULL
Since	NULL
several	NULL
nuclear	NULL
oncoproteins	NULL
render	NULL
cells	NULL
susceptible	NULL
to	NULL
apoptosis	NULL
(	NULL
e.g	NULL
.	NULL

ElA	NULL
,	NULL
Myc	NULL
and	NULL
E2F	NULL
)	NULL
by	NULL
inducing	NULL
cell	NULL
cycle	NULL
progression	NULL
(	NULL
Debbas	NULL
and	NULL
White	NULL
,	NULL
1993	NULL
;	NULL
Hermeking	NULL
and	NULL
Eick	NULL
,	NULL
1994	NULL
;	NULL
Shan	NULL
and	NULL
Lee	NULL
,	NULL
1994	NULL
)	NULL
,	NULL
we	NULL
investigated	NULL
whether	NULL
EZa-Pbx1	NULL
may	NULL
share	NULL
similar	NULL
properties	NULL
.	NULL

These	NULL
studies	NULL
were	NULL
conducted	NULL
in	NULL
Rat-l	NULL
fibroblasts	NULL
since	NULL
Reh	NULL
cells	NULL
did	NULL
not	NULL
tolerate	NULL
arrest	NULL
and	NULL
concurrent	NULL
treatment	NULL
with	NULL
ZnSO	NULL
,	NULL
Rat-l1	NULL
fibroblasts	NULL
,	NULL
unlike	NULL
Reh	NULL
,	NULL
support	NULL
constitutive	NULL
expression	NULL
of	NULL
EZa-Pbx1	NULL
without	NULL
undergoing	NULL
apoptosis	NULL
(	NULL
Figure	NULL
7	NULL
)	NULL
.	NULL

Stably	NULL
transfected	NULL
,	NULL
cloned	NULL
Rat-1	NULL
cells	NULL
expressing	NULL
EZa-Pbx1	NULL
,	NULL
c-myc	NULL
,	NULL
or	NULL
containing	NULL
vector	NULL
alone	NULL
were	NULL
grown	NULL
to	NULL
logarithmic	NULL
phase	NULL
and	NULL
transferred	NULL
to	NULL
0.1	NULL
%	NULL
FCS	NULL
.	NULL

The	NULL
c-myc-expressing	NULL
cells	NULL
began	NULL
undergoing	NULL
apoptosis	NULL
within	NULL
hours	NULL
of	NULL
serum	NULL
starvation	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
Rat-1/	NULL
E2a-Pbx1	NULL
showed	NULL
only	NULL
background	NULL
levels	NULL
of	NULL
apoptosis	NULL
comparable	NULL
to	NULL
the	NULL
control	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

After	NULL
serum	NULL
starvation	NULL
for	NULL
72	NULL
h	NULL
,	NULL
Rat-l/mye	NULL
and	NULL
Rat-1/E2a-Pbx1	NULL
cells	NULL
were	NULL
analysed	NULL
for	NULL
total	NULL
DNA	NULL
content	NULL
by	NULL
FACS	NULL
.	NULL

Rat-l/myc	NULL
cells	NULL
remained	NULL
in	NULL
cycle	NULL
(	NULL
17.8	NULL
%	NULL
S	NULL
phase	NULL
cells	NULL
)	NULL
similar	NULL
to	NULL
Rat-l/vector	NULL
cells	NULL
growing	NULL
in	NULL
10	NULL
%	NULL
FCS	NULL
(	NULL
21.2	NULL
%	NULL
S	NULL
phase	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
Rat-1/E2a-Pbx1	NULL
and	NULL
Rat-l/vector	NULL
cells	NULL
in	NULL
0.1	NULL
%	NULL
FCS	NULL
showed	NULL
considerably	NULL
smaller	NULL
S	NULL
phase	NULL
fractions	NULL
(	NULL
5.4	NULL
%	NULL
and	NULL
8.7	NULL
%	NULL
,	NULL
respectively	NULL
)	NULL
consistent	NULL
with	NULL
growth	NULL
arrest	NULL
(	NULL
Figure	NULL
7a	NULL
)	NULL
.	NULL

Apoptosis	NULL
of	NULL
Rat-l/mye	NULL
cells	NULL
was	NULL
evident	NULL
by	NULL
the	NULL
large	NULL
fraction	NULL
containing	NULL
sub-G1	NULL
DNA	NULL
content	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
cells	NULL
actively	NULL
traversing	NULL
S	NULL
phase	NULL
was	NULL
quantitated	NULL
by	NULL
metabolic	NULL
labeling	NULL
with	NULL
100	NULL
uM	NULL
BrdU	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Rat-l/mye	NULL
cells	NULL
incubated	NULL
in	NULL
0.1	NULL
%	NULL
serum	NULL
displayed	NULL
an	NULL
S	NULL
phase	NULL
fraction	NULL
(	NULL
30.0	NULL
%	NULL
)	NULL
comparable	NULL
to	NULL
Rat-1/vector	NULL
cells	NULL
in	NULL
10	NULL
%	NULL
serum	NULL
(	NULL
28.6	NULL
%	NULL
)	NULL
.	NULL

By	NULL
comparison	NULL
,	NULL
Rat-1/E2a-Pbx1	NULL
and	NULL
Rat-l1/vector	NULL
cells	NULL
incubated	NULL
in	NULL
0.1	NULL
%	NULL
serum	NULL
displayed	NULL
S	NULL
phase	NULL
fractions	NULL
of	NULL
13.9	NULL
%	NULL
and	NULL
8.6	NULL
%	NULL
,	NULL
respectively	NULL
.	NULL

Therefore	NULL
,	NULL
under	NULL
low-serum	NULL
conditions	NULL
in	NULL
which	NULL
constitutive	NULL
mye	NULL
expression	NULL
induces	NULL
cell	NULL
cycling	NULL
and	NULL
concomitant	NULL
apoptosis	NULL
of	NULL
Rat-l	NULL
fibroblasts	NULL
,	NULL
no	NULL
comparable	NULL
effects	NULL
are	NULL
evident	NULL
from	NULL
forced	NULL
expression	NULL
of	NULL
EZa-Pbx1	NULL
.	NULL

These	NULL
data	NULL
provide	NULL
additional	NULL
evidence	NULL
that	NULL
the	NULL
oncoproteins	NULL
EZa-Pbx1	NULL
and	NULL
c-myc	NULL
differ	NULL
in	NULL
the	NULL
mechanisms	NULL
by	NULL
which	NULL
they	NULL
render	NULL
cells	NULL
susceptible	NULL
to	NULL
apoptosis	NULL
.	NULL

Discussion	NULL
In	NULL
this	NULL
report	NULL
we	NULL
show	NULL
that	NULL
chimeric	NULL
oncoprotein	NULL
EZa-Pbx1	NULL
induces	NULL
apoptosis	NULL
of	NULL
hematopoietic	NULL
precursor	NULL
cell	NULL
lines	NULL
in	NULL
vitro	NULL
and	NULL
provide	NULL
evidence	NULL
that	NULL
it	NULL
initiates	NULL
this	NULL
process	NULL
by	NULL
a	NULL
mechanism	NULL
that	NULL
differs	NULL
from	NULL
other	NULL
nuclear	NULL
oncoproteins	NULL
.	NULL

To	NULL
demonstrate	NULL
these	NULL
phenomena	NULL
,	NULL
we	NULL
employed	NULL
a	NULL
conditional	NULL
expression	NULL
system	NULL
because	NULL
previous	NULL
attempts	NULL
to	NULL
constitutively	NULL
express	NULL
EZa-Pbx1	NULL
in	NULL
lymphoid	NULL
cell	NULL
lines	NULL
were	NULL
unsuccessful	NULL
.	NULL

The	NULL
levels	NULL
of	NULL
induced	NULL
EZa-Pbx1	NULL
expression	NULL
achieved	NULL
in	NULL
our	NULL
experiments	NULL
approximated	NULL
steady-state	NULL
levels	NULL
of	NULL
wild	NULL
type	NULL
EZa	NULL
proteins	NULL
in	NULL
B	NULL
lineage	NULL
precursor	NULL
cell	NULL
lines	NULL
.	NULL

These	NULL
600	NULL
800	NULL
i	NULL
Rat-1/Vector	NULL
|	NULL
0.1	NULL
%	NULL
Serum	NULL
Rat-1Nector	NULL
10	NULL
%	NULL
Serum	NULL
200	NULL
400	NULL
400	NULL
600	NULL
200	NULL
Â§	NULL
Rat-1/E2a-Pbx1	NULL
_	NULL
Â§	NULL
4	NULL
Rat-1/myc	NULL
h	NULL
0.1	NULL
%	NULL
Serum	NULL
0.1	NULL
%	NULL
Serum	NULL
o	NULL
50	NULL
100	NULL
150	NULL
0	NULL
50	NULL
100	NULL
150	NULL
DNA	NULL
Content	NULL
b	NULL
Â«	NULL
-	NULL
w	NULL
at	NULL
s	NULL
w	NULL
a	NULL
f=	NULL
C	NULL
&	NULL
2	NULL
&	NULL
J	NULL
a	NULL
E2a-Pbx1b	NULL
wee	NULL
-	NULL
WtE2a	NULL
Figure	NULL
7	NULL
-	NULL
Rat-1/E2a-Pbx1	NULL
cells	NULL
growth	NULL
arrest	NULL
without	NULL
undergoing	NULL
apoptosis	NULL
in	NULL
low	NULL
serum	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Logarithmically	NULL
growing	NULL
Rat-1/E2a-Pbx1	NULL
,	NULL
Rat-1/c-myc	NULL
,	NULL
or	NULL
vector-only	NULL
control	NULL
cells	NULL
were	NULL
placed	NULL
in	NULL
D-0.1	NULL
%	NULL
FCS	NULL
for	NULL
72	NULL
h.	NULL
Cells	NULL
were	NULL
then	NULL
lysed	NULL
in	NULL
buffer	NULL
containing	NULL
propidium	NULL
iodide	NULL
and	NULL
nuclei	NULL
were	NULL
analysed	NULL
by	NULL
FACS	NULL
.	NULL

DNA	NULL
content	NULL
was	NULL
calculated	NULL
using	NULL
the	NULL
ModFit	NULL
program	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
San	NULL
Jose	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Colored	NULL
peaks	NULL
correspond	NULL
to	NULL
relative	NULL
numbers	NULL
of	NULL
cells	NULL
with	NULL
2n	NULL
or	NULL
4n	NULL
(	NULL
red	NULL
)	NULL
,	NULL
S	NULL
phase	NULL
(	NULL
dark	NULL
blue	NULL
)	NULL
or	NULL
sub	NULL
G1	NULL
(	NULL
light	NULL
blue	NULL
)	NULL
DNA	NULL
content	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Constitutive	NULL
expression	NULL
of	NULL
EZa-Pbx1	NULL
in	NULL
Rat-1	NULL
cells	NULL
.	NULL

Total	NULL
cellular	NULL
proteins	NULL
from	NULL
Rat-1/E2a-Pbx1	NULL
clones	NULL
were	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
followed	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
using	NULL
an	NULL
anti-E2a	NULL
antibody	NULL
.	NULL

Clone	NULL
#	NULL
1	NULL
displayed	NULL
high	NULL
level	NULL
constitutive	NULL
expression	NULL
of	NULL
EZa-Pbx1b	NULL
and	NULL
was	NULL
employed	NULL
for	NULL
DNA	NULL
content	NULL
studies	NULL
Table	NULL
1	NULL
Cell	NULL
cycle	NULL
analysis	NULL
of	NULL
Rat-1	NULL
clones	NULL
Cell	NULL
lines	NULL
Percent	NULL
of	NULL
cells	NULL
in	NULL
S	NULL
phase	NULL
FACS	NULL
BrdU	NULL
10	NULL
%	NULL
0.1	NULL
%	NULL
10	NULL
%	NULL
0.1	NULL
%	NULL
Rat-1/myc	NULL
nd	NULL
17.8	NULL
nd	NULL
28.6	NULL
Rat-1/E2a-Pbx1	NULL
nd	NULL
5.4	NULL
nd	NULL
13.9	NULL
Rat-1/vector	NULL
21.2	NULL
8.7	NULL
30.0	NULL
8.6	NULL
levels	NULL
are	NULL
also	NULL
comparable	NULL
to	NULL
those	NULL
of	NULL
EZa-Pbx1	NULL
proteins	NULL
expressed	NULL
under	NULL
control	NULL
of	NULL
the	NULL
E2A	NULL
promoter	NULL
in	NULL
t	NULL
(	NULL
l	NULL
;	NULL
19	NULL
)	NULL
-bearing	NULL
leukemia	NULL
cells	NULL
Therefore	NULL
,	NULL
the	NULL
observed	NULL
effects	NULL
on	NULL
cell	NULL
survival	NULL
are	NULL
a	NULL
biologic	NULL
property	NULL
of	NULL
EZa-Pbx1	NULL
at	NULL
intracellular	NULL
concentrations	NULL
characteristic	NULL
of	NULL
human	NULL
disease	NULL
states	NULL
and	NULL
not	NULL
simply	NULL
a	NULL
consequence	NULL
of	NULL
massive	NULL
experimental	NULL
over-expression	NULL
.	NULL

These	NULL
studies	NULL
extend	NULL
previous	NULL
work	NULL
on	NULL
E2A-PBX1	NULL
transgenic	NULL
mice	NULL
which	NULL
initially	NULL
suggested	NULL
that	NULL
EZa-Pbx1	NULL
was	NULL
capable	NULL
of	NULL
rendering	NULL
thymocytes	NULL
susceptible	NULL
to	NULL
apoptosis	NULL
(	NULL
Dedera	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Increased	NULL
numbers	NULL
of	NULL
apoptotic	NULL
cells	NULL
were	NULL
measured	NULL
in	NULL
thymuses	NULL
of	NULL
these	NULL
mice	NULL
.	NULL

Profound	NULL
lymphopenias	NULL
of	NULL
both	NULL
T	NULL
and	NULL
B	NULL
cells	NULL
were	NULL
observed	NULL
prior	NULL
to	NULL
development	NULL
of	NULL
lymphoblastic	NULL
malignancies	NULL
,	NULL
however	NULL
the	NULL
cellular	NULL
basis	NULL
for	NULL
these	NULL
effects	NULL
were	NULL
not	NULL
established	NULL
.	NULL

Our	NULL
current	NULL
studies	NULL
suggest	NULL
that	NULL
the	NULL
observed	NULL
lymphopenias	NULL
in	NULL
transgenic	NULL
animals	NULL
were	NULL
a	NULL
direct	NULL
result	NULL
of	NULL
adverse	NULL
effects	NULL
in	NULL
vivo	NULL
by	NULL
EZa-Pbx1l	NULL
on	NULL
the	NULL
survival	NULL
of	NULL
lymphoid	NULL
progenitors	NULL
comparable	NULL
to	NULL
those	NULL
we	NULL
found	NULL
in	NULL
vitro	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
EZ2a-Pbx1	NULL
has	NULL
the	NULL
capability	NULL
to	NULL
modulate	NULL
both	NULL
the	NULL
survival	NULL
and	NULL
neoplastic	NULL
properties	NULL
of	NULL
lymphoid	NULL
progenitors	NULL
.	NULL

Mutational	NULL
analyses	NULL
indicated	NULL
that	NULL
EZa-Pbx1	NULL
requires	NULL
its	NULL
activity	NULL
as	NULL
a	NULL
transcription	NULL
factor	NULL
to	NULL
promote	NULL
apoptosis	NULL
.	NULL

Deletion	NULL
of	NULL
all	NULL
Pbx-derived	NULL
sequences	NULL
from	NULL
E2a-Pbx1	NULL
eliminated	NULL
its	NULL
apoptotic	NULL
activity	NULL
indicating	NULL
that	NULL
cell	NULL
death	NULL
was	NULL
not	NULL
induced	NULL
by	NULL
possible	NULL
dominant-negative	NULL
effects	NULL
of	NULL
EZa	NULL
lacking	NULL
its	NULL
carboxy-terminal	NULL
bHLH	NULL
DNA-binding	NULL
and	NULL
dimerization	NULL
motifs	NULL
.	NULL

This	NULL
possibility	NULL
was	NULL
raised	NULL
by	NULL
previous	NULL
observations	NULL
that	NULL
the	NULL
amino-terminal	NULL
portion	NULL
of	NULL
EZa	NULL
lacking	NULL
its	NULL
bHLH	NULL
motifs	NULL
has	NULL
growth	NULL
inhibitory	NULL
properties	NULL
in	NULL
fibroblasts	NULL
(	NULL
Peverali	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
,	NULL
however	NULL
our	NULL
studies	NULL
exclude	NULL
this	NULL
as	NULL
the	NULL
basis	NULL
for	NULL
EZ2a-Pbx1l-induced	NULL
apoptosis	NULL
.	NULL

Rather	NULL
,	NULL
apoptosis	NULL
resulted	NULL
from	NULL
expression	NULL
of	NULL
chimeric	NULL
proteins	NULL
containing	NULL
N-terminal	NULL
E2a	NULL
fused	NULL
to	NULL
specific	NULL
portions	NULL
of	NULL
Pbx1	NULL
.	NULL

The	NULL
minimal	NULL
portion	NULL
of	NULL
Pbx1l	NULL
required	NULL
for	NULL
apoptosis	NULL
consisted	NULL
of	NULL
its	NULL
homeodomain	NULL
and	NULL
12	NULL
flanking	NULL
amino	NULL
acids	NULL
.	NULL

The	NULL
latter	NULL
constitute	NULL
a	NULL
conserved	NULL
motif	NULL
(	NULL
named	NULL
the	NULL
Hox	NULL
cooperativity	NULL
motif	NULL
or	NULL
HCM	NULL
)	NULL
that	NULL
also	NULL
serves	NULL
important	NULL
roles	NULL
for	NULL
the	NULL
transcriptional	NULL
and	NULL
transforming	NULL
activities	NULL
of	NULL
EZa-Pbx1	NULL
(	NULL
Chang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

As	NULL
summarized	NULL
in	NULL
Table	NULL
2	NULL
,	NULL
there	NULL
is	NULL
consistent	NULL
absence	NULL
of	NULL
biological	NULL
or	NULL
transcriptional	NULL
activity	NULL
for	NULL
minimal	NULL
construct	NULL
HD	NULL
;	NULL
;	NULL
;	NULL
_	NULL
;	NULL
;	NULL
,	NULL
which	NULL
lacks	NULL
the	NULL
HCM	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
activity	NULL
of	NULL
HD	NULL
Â»	NULL
Â»	NULL
Â»	NULL
,	NULL
which	NULL
contains	NULL
both	NULL
the	NULL
Pbx1	NULL
homeodomain	NULL
and	NULL
HCM	NULL
.	NULL

Based	NULL
on	NULL
mutational	NULL
studies	NULL
and	NULL
molecular	NULL
modeling	NULL
(	NULL
Chang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
,	NULL
the	NULL
HCM	NULL
is	NULL
predicted	NULL
to	NULL
serve	NULL
as	NULL
a	NULL
site	NULL
of	NULL
contact	NULL
for	NULL
heterologous	NULL
DNA-binding	NULL
partners	NULL
such	NULL
Table	NULL
2	NULL
Comparative	NULL
biological	NULL
and	NULL
transcriptional	NULL
properties	NULL
of	NULL
E2a	NULL
chimeric	NULL
proteins	NULL
DNA-	NULL
Trans-	NULL
Trans-Construct	NULL
binding	NULL
â	NULL
activation	NULL
``	NULL
formation	NULL
â	NULL
Apoptosis	NULL
E2a-Pbxla	NULL
+	NULL
+	NULL
+	NULL
+	NULL
E2a-Pbx1b	NULL
+	NULL
+	NULL
+	NULL
+	NULL
A299-308	NULL
+	NULL
``	NULL
+	NULL
``	NULL
-	NULL
+	NULL
1bAHD	NULL
-	NULL
-	NULL
+	NULL
A232-430	NULL
-	NULL
-	NULL
-	NULL
HD232-310	NULL
+	NULL
+	NULL
+	NULL
+	NULL
HD232-298	NULL
-	NULL
-	NULL
-	NULL
APbx1	NULL
-	NULL
-	NULL
-	NULL
E2a-HIf	NULL
+	NULL
+	NULL
+	NULL
*These	NULL
data	NULL
are	NULL
summarized	NULL
from	NULL
previous	NULL
reports	NULL
(	NULL
Chang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
,	NULL
1997	NULL
;	NULL
Hunger	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Inaba	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Monica	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

DNA-binding	NULL
and	NULL
transcriptional	NULL
activation	NULL
for	NULL
Pbx	NULL
chimeras	NULL
were	NULL
assessed	NULL
on	NULL
a	NULL
PBX	NULL
consensus	NULL
site	NULL
(	NULL
Lebrun	NULL
and	NULL
Cleary	NULL
,	NULL
1994	NULL
)	NULL
and	NULL
for	NULL
E2a-HIf	NULL
on	NULL
an	NULL
HLF	NULL
consensus	NULL
site	NULL
(	NULL
Hunger	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

``	NULL
The	NULL
DNA-binding	NULL
and	NULL
transcriptional	NULL
properties	NULL
of	NULL
this	NULL
construct	NULL
vary	NULL
depending	NULL
on	NULL
the	NULL
binding	NULL
site	NULL
employed	NULL
(	NULL
Chang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
Apoptsosis	NULL
induced	NULL
in	NULL
vitro	NULL
by	NULL
EZa-Pbx1	NULL
KS	NULL
Smith	NULL
et	NULL
al	NULL
as	NULL
class	NULL
I	NULL
Hox	NULL
proteins	NULL
.	NULL

Given	NULL
the	NULL
requirement	NULL
for	NULL
the	NULL
HCM	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
E2a-Pbx1	NULL
must	NULL
function	NULL
as	NULL
a	NULL
transcriptional	NULL
protein	NULL
recognizing	NULL
subordinate	NULL
targets	NULL
in	NULL
the	NULL
context	NULL
of	NULL
heterologous	NULL
DNA-binding	NULL
partners	NULL
to	NULL
effect	NULL
apoptosis	NULL
.	NULL

However	NULL
,	NULL
there	NULL
are	NULL
distinct	NULL
differences	NULL
in	NULL
the	NULL
structural	NULL
requirements	NULL
for	NULL
apoptosis	NULL
versus	NULL
transformation	NULL
that	NULL
provide	NULL
additional	NULL
insights	NULL
into	NULL
potential	NULL
mechanisms	NULL
that	NULL
may	NULL
underlie	NULL
these	NULL
biological	NULL
properties	NULL
of	NULL
EZa-Pbxl	NULL
.	NULL

For	NULL
instance	NULL
,	NULL
construct	NULL
1bAHD	NULL
,	NULL
lacking	NULL
the	NULL
Pbx1	NULL
homeodomain	NULL
,	NULL
was	NULL
incapable	NULL
of	NULL
inducing	NULL
apoptosis	NULL
in	NULL
contrast	NULL
to	NULL
its	NULL
ability	NULL
to	NULL
transform	NULL
fibroblasts	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
shown	NULL
that	NULL
the	NULL
homeodomain-independent	NULL
transforming	NULL
properties	NULL
of	NULL
E2a-Pbx1	NULL
are	NULL
critically	NULL
dependent	NULL
on	NULL
the	NULL
Pbx	NULL
HCM	NULL
(	NULL
Chang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

Based	NULL
on	NULL
the	NULL
findings	NULL
that	NULL
subtle	NULL
alterations	NULL
of	NULL
the	NULL
Pbx	NULL
HCM	NULL
resulted	NULL
in	NULL
complete	NULL
abrogation	NULL
of	NULL
transforming	NULL
activity	NULL
whereas	NULL
the	NULL
homeodomain	NULL
was	NULL
entirely	NULL
dispensible	NULL
,	NULL
we	NULL
concluded	NULL
that	NULL
heterologous	NULL
protein-protein	NULL
interactions	NULL
mediated	NULL
by	NULL
the	NULL
HCM	NULL
are	NULL
more	NULL
important	NULL
for	NULL
transformation	NULL
by	NULL
EZa-Pbx1	NULL
than	NULL
interactions	NULL
with	NULL
cognate	NULL
Pbx	NULL
DNA	NULL
sites	NULL
.	NULL

However	NULL
,	NULL
a	NULL
similar	NULL
conclusion	NULL
does	NULL
not	NULL
apply	NULL
to	NULL
E2a-Pbx1l-induced	NULL
apoptosis	NULL
where	NULL
Pbx-DNA	NULL
interactions	NULL
appear	NULL
to	NULL
be	NULL
essential	NULL
based	NULL
on	NULL
the	NULL
inability	NULL
of	NULL
1bAHD	NULL
to	NULL
induce	NULL
apoptosis	NULL
.	NULL

These	NULL
disparate	NULL
findings	NULL
are	NULL
likely	NULL
to	NULL
reflect	NULL
the	NULL
requirement	NULL
for	NULL
different	NULL
DNA-binding	NULL
partners	NULL
to	NULL
interact	NULL
with	NULL
EZ2a-Pbx1	NULL
to	NULL
recognize	NULL
subordinate	NULL
target	NULL
genes	NULL
involved	NULL
in	NULL
apoptosis	NULL
versus	NULL
transformation	NULL
.	NULL

This	NULL
suggestion	NULL
is	NULL
supported	NULL
by	NULL
results	NULL
from	NULL
construct	NULL
A299-308	NULL
,	NULL
containing	NULL
a	NULL
subtotal	NULL
deletion	NULL
of	NULL
the	NULL
HCM	NULL
,	NULL
which	NULL
retains	NULL
partial	NULL
apoptotic	NULL
potential	NULL
but	NULL
lacks	NULL
transforming	NULL
activity	NULL
.	NULL

In	NULL
transcriptional	NULL
and	NULL
DNA-binding	NULL
assays	NULL
,	NULL
A299-308	NULL
shows	NULL
variable	NULL
activity	NULL
dependent	NULL
on	NULL
which	NULL
Hox	NULL
proteins	NULL
are	NULL
provided	NULL
as	NULL
DNA-binding	NULL
partners	NULL
(	NULL
Table	NULL
2	NULL
and	NULL
Chang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

These	NULL
differences	NULL
may	NULL
be	NULL
attributable	NULL
to	NULL
the	NULL
variable	NULL
structural	NULL
requirements	NULL
of	NULL
different	NULL
partners	NULL
for	NULL
HCM	NULL
interactions	NULL
which	NULL
are	NULL
unmasked	NULL
by	NULL
subtotal	NULL
disruption	NULL
of	NULL
the	NULL
HCM	NULL
by	NULL
the	NULL
A299-308	NULL
deletion	NULL
.	NULL

A	NULL
specific	NULL
role	NULL
for	NULL
the	NULL
Pbx	NULL
moiety	NULL
of	NULL
EZa-Pbx1	NULL
in	NULL
potentiating	NULL
apoptosis	NULL
is	NULL
further	NULL
demonstrated	NULL
by	NULL
the	NULL
inability	NULL
of	NULL
EZ2a-HIf	NULL
to	NULL
render	NULL
Reh	NULL
cells	NULL
susceptible	NULL
to	NULL
apoptosis	NULL
.	NULL

EZa-HIf	NULL
,	NULL
like	NULL
EZa-Pbx1	NULL
,	NULL
is	NULL
a	NULL
chimeric	NULL
transcriptional	NULL
protein	NULL
resulting	NULL
from	NULL
chromosomal	NULL
translocations	NULL
in	NULL
B	NULL
cell	NULL
precursor	NULL
leukemias	NULL
,	NULL
however	NULL
EZa-HIf	NULL
contains	NULL
a	NULL
basic	NULL
DNA-binding	NULL
region	NULL
and	NULL
leucine	NULL
zipper	NULL
dimerization	NULL
motif	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
homeodomain	NULL
contained	NULL
by	NULL
EZa-Pbx1	NULL
.	NULL

As	NULL
a	NULL
conse-quence	NULL
,	NULL
EZa-HIf	NULL
binds	NULL
and	NULL
activates	NULL
transcription	NULL
through	NULL
DNA	NULL
sites	NULL
different	NULL
from	NULL
those	NULL
recognized	NULL
by	NULL
EZ2a-Pbx1	NULL
or	NULL
wild	NULL
type	NULL
E2a	NULL
proteins	NULL
(	NULL
Hunger	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Inaba	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
forced	NULL
expression	NULL
of	NULL
EZ2a-HIf	NULL
prevents	NULL
precursor	NULL
B	NULL
cells	NULL
of	NULL
the	NULL
BaF3	NULL
cell	NULL
line	NULL
from	NULL
undergoing	NULL
apoptosis	NULL
in	NULL
response	NULL
to	NULL
IL3	NULL
withdrawal	NULL
(	NULL
Inaba	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
raise	NULL
the	NULL
possibility	NULL
that	NULL
HIf	NULL
targets	NULL
may	NULL
equate	NULL
with	NULL
survival	NULL
whereas	NULL
Pbx	NULL
targets	NULL
may	NULL
equate	NULL
with	NULL
apoptosis	NULL
.	NULL

However	NULL
,	NULL
we	NULL
have	NULL
not	NULL
observed	NULL
enhanced	NULL
survival	NULL
of	NULL
lymphoid	NULL
precursors	NULL
expressing	NULL
E2a-HIf	NULL
in	NULL
vitro	NULL
or	NULL
in	NULL
EZ2a-HIf	NULL
transgenic	NULL
mice	NULL
(	NULL
Smith	NULL
and	NULL
Cleary	NULL
,	NULL
unpublished	NULL
observation	NULL
)	NULL
suggesting	NULL
that	NULL
there	NULL
are	NULL
cell-type	NULL
specific	NULL
differences	NULL
in	NULL
responses	NULL
to	NULL
chimeric	NULL
HIf	NULL
as	NULL
well	NULL
as	NULL
Pbx	NULL
proteins	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
Pbx	NULL
,	NULL
this	NULL
may	NULL
in	NULL
part	NULL
reflect	NULL
the	NULL
spectrum	NULL
of	NULL
2923	NULL
Apoptsosis	NULL
induced	NULL
in	NULL
vitro	NULL
by	NULL
EZa-Pbx1	NULL
KS	NULL
Smith	NULL
et	NULL
al	NULL
2924	NULL
endogenously	NULL
expressed	NULL
Hox	NULL
proteins	NULL
displaying	NULL
different	NULL
sequence	NULL
specificities	NULL
as	NULL
cooperative	NULL
DNA-binding	NULL
complexes	NULL
with	NULL
E2a-Pbx1	NULL
.	NULL

The	NULL
large	NULL
repertoire	NULL
of	NULL
Hox	NULL
proteins	NULL
would	NULL
allow	NULL
for	NULL
a	NULL
range	NULL
of	NULL
potential	NULL
functional	NULL
outcomes	NULL
.	NULL

Our	NULL
studies	NULL
show	NULL
that	NULL
EZa-Pbx1-induced	NULL
apoptosis	NULL
proceeds	NULL
ultimately	NULL
through	NULL
a	NULL
Bel-2-regulated	NULL
checkpoint	NULL
and	NULL
eventuates	NULL
in	NULL
PARP	NULL
inactivation	NULL
.	NULL

These	NULL
results	NULL
strongly	NULL
implicate	NULL
the	NULL
activation	NULL
of	NULL
a	NULL
protease	NULL
belonging	NULL
to	NULL
the	NULL
CED3/ICE	NULL
family	NULL
of	NULL
serine	NULL
proteases	NULL
,	NULL
a	NULL
group	NULL
shown	NULL
to	NULL
contain	NULL
several	NULL
diverse	NULL
members	NULL
functionally	NULL
able	NULL
to	NULL
cleave	NULL
PARP	NULL
whose	NULL
proteolysis	NULL
is	NULL
a	NULL
marker	NULL
of	NULL
apoptosis	NULL
initiated	NULL
by	NULL
several	NULL
stimuli	NULL
(	NULL
Lippke	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Schlegel	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Tewari	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

We	NULL
obtained	NULL
no	NULL
evidence	NULL
that	NULL
EZa-Pbxl-associated	NULL
apoptosis	NULL
was	NULL
due	NULL
to	NULL
primary	NULL
perturbations	NULL
of	NULL
this	NULL
checkpoint	NULL
due	NULL
to	NULL
alterations	NULL
in	NULL
the	NULL
level	NULL
of	NULL
proteins	NULL
such	NULL
as	NULL
Bcel-2	NULL
,	NULL
Mcl-1	NULL
or	NULL
Bax	NULL
,	NULL
although	NULL
down-regulation	NULL
of	NULL
Bel-2	NULL
may	NULL
be	NULL
a	NULL
late	NULL
effect	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
molecular	NULL
events	NULL
between	NULL
transcriptional	NULL
induction	NULL
of	NULL
EZa-Pbx1	NULL
subordinate	NULL
genes	NULL
and	NULL
protease	NULL
activation	NULL
remain	NULL
unknown	NULL
.	NULL

Potential	NULL
genes	NULL
that	NULL
are	NULL
regulated	NULL
in	NULL
part	NULL
by	NULL
contributions	NULL
from	NULL
Pbx-like	NULL
proteins	NULL
have	NULL
been	NULL
identified	NULL
through	NULL
genetic	NULL
analyses	NULL
in	NULL
Drosophila	NULL
.	NULL

The	NULL
Drosophila	NULL
homologue	NULL
of	NULL
Pbx1	NULL
,	NULL
extradenticle	NULL
(	NULL
exd	NULL
)	NULL
,	NULL
functions	NULL
in	NULL
parallel	NULL
with	NULL
homeotic	NULL
selector	NULL
genes	NULL
abdominal	NULL
A	NULL
(	NULL
abd-A	NULL
)	NULL
,	NULL
antennapedia	NULL
(	NULL
Antp	NULL
)	NULL
,	NULL
and	NULL
ultrabithorax	NULL
(	NULL
Ubx	NULL
)	NULL
(	NULL
Rauskolb	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
in	NULL
regulating	NULL
downstream	NULL
genes	NULL
essential	NULL
in	NULL
determining	NULL
body	NULL
segment	NULL
identity	NULL
(	NULL
Rauskolb	NULL
and	NULL
Wieschaus	NULL
,	NULL
1994	NULL
)	NULL
.	NULL

Subordinate	NULL
genes	NULL
include	NULL
wingless	NULL
and	NULL
deca-pentaplegic	NULL
(	NULL
dpp	NULL
)	NULL
,	NULL
which	NULL
code	NULL
for	NULL
signaling	NULL
molecules	NULL
of	NULL
the	NULL
Wat	NULL
and	NULL
TGFR	NULL
families	NULL
,	NULL
respectively	NULL
.	NULL

Furthermore	NULL
the	NULL
human	NULL
homologue	NULL
of	NULL
dpp	NULL
was	NULL
identified	NULL
as	NULL
bone	NULL
morphogenetic	NULL
factor	NULL
4	NULL
(	NULL
BMP-4	NULL
)	NULL
a	NULL
signaling	NULL
molecule	NULL
shown	NULL
to	NULL
be	NULL
required	NULL
for	NULL
interdigital	NULL
apoptosis	NULL
within	NULL
the	NULL
developing	NULL
chick	NULL
limb	NULL
(	NULL
Zou	NULL
and	NULL
Niswander	NULL
,	NULL
1996	NULL
)	NULL
.	NULL

Pbx	NULL
has	NULL
also	NULL
been	NULL
implicated	NULL
as	NULL
a	NULL
cofactor	NULL
with	NULL
the	NULL
non-Hox	NULL
homeodomain	NULL
protein	NULL
STF-1	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
somatostatin	NULL
gene	NULL
expression	NULL
(	NULL
Peers	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

These	NULL
data	NULL
are	NULL
consistent	NULL
with	NULL
possible	NULL
signaling	NULL
molecules	NULL
or	NULL
cytokines	NULL
as	NULL
products	NULL
of	NULL
primary	NULL
targets	NULL
misregulated	NULL
by	NULL
EZa-Pbx1	NULL
in	NULL
lymphoid	NULL
precursors	NULL
.	NULL

We	NULL
are	NULL
currently	NULL
investigating	NULL
the	NULL
potential	NULL
role	NULL
of	NULL
TGFR	NULL
family	NULL
members	NULL
and	NULL
FAS	NULL
ligand	NULL
which	NULL
are	NULL
implicated	NULL
in	NULL
modulating	NULL
lymphocyte	NULL
survival	NULL
in	NULL
other	NULL
settings	NULL
.	NULL

Additional	NULL
findings	NULL
further	NULL
suggest	NULL
that	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
EZa-Pbx1	NULL
renders	NULL
cells	NULL
susceptible	NULL
to	NULL
apoptosis	NULL
may	NULL
be	NULL
fundamentally	NULL
different	NULL
than	NULL
those	NULL
employed	NULL
by	NULL
other	NULL
nuclear	NULL
oncoproteins	NULL
.	NULL

Most	NULL
sig-nificantly	NULL
,	NULL
EZa-Pbxl-induced	NULL
apoptosis	NULL
displays	NULL
no	NULL
requirement	NULL
for	NULL
tumor	NULL
suppressor	NULL
protein	NULL
p53	NULL
.	NULL

Although	NULL
p53	NULL
levels	NULL
increased	NULL
following	NULL
zinc	NULL
treatment	NULL
of	NULL
Reh	NULL
cells	NULL
,	NULL
comparable	NULL
increases	NULL
were	NULL
observed	NULL
regardless	NULL
of	NULL
whether	NULL
the	NULL
cells	NULL
expressed	NULL
EZa-Pbx1	NULL
.	NULL

However	NULL
,	NULL
Reh	NULL
cells	NULL
were	NULL
shown	NULL
to	NULL
be	NULL
responsive	NULL
to	NULL
p53-mediated	NULL
apoptosis	NULL
induced	NULL
by	NULL
ionizing	NULL
radiation	NULL
(	NULL
Smith	NULL
and	NULL
Cleary	NULL
,	NULL
unpublished	NULL
observation	NULL
)	NULL
.	NULL

Apoptosis	NULL
was	NULL
also	NULL
observed	NULL
in	NULL
HL-60	NULL
myeloid	NULL
progenitor	NULL
cells	NULL
which	NULL
do	NULL
not	NULL
express	NULL
functional	NULL
p53	NULL
protein	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
p53	NULL
requirement	NULL
differs	NULL
from	NULL
apoptosis	NULL
associated	NULL
with	NULL
forced	NULL
expression	NULL
of	NULL
c-myc	NULL
or	NULL
adenoviral	NULL
ElA	NULL
proteins	NULL
,	NULL
whose	NULL
effects	NULL
on	NULL
cell	NULL
cycle	NULL
progression	NULL
generate	NULL
signals	NULL
that	NULL
pass	NULL
through	NULL
a	NULL
p53	NULL
checkpoint	NULL
to	NULL
eventuate	NULL
in	NULL
cell	NULL
death	NULL
(	NULL
Debbas	NULL
and	NULL
White	NULL
,	NULL
1993	NULL
;	NULL
Hermeking	NULL
and	NULL
Eick	NULL
,	NULL
1994	NULL
)	NULL
.	NULL

By	NULL
comparison	NULL
,	NULL
EZa-Pbxl1	NULL
_	NULL
induced	NULL
apoptosis	NULL
of	NULL
hematolymphoid	NULL
cells	NULL
under	NULL
normal	NULL
growth	NULL
conditions	NULL
and	NULL
did	NULL
not	NULL
obviously	NULL
perturb	NULL
the	NULL
cycling	NULL
activity	NULL
of	NULL
Reh	NULL
cells	NULL
(	NULL
Smith	NULL
and	NULL
Cleary	NULL
,	NULL
unpublished	NULL
observation	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
constitutive	NULL
expression	NULL
of	NULL
EZa-Pbx1	NULL
was	NULL
incapable	NULL
of	NULL
sustaining	NULL
continued	NULL
cycling	NULL
of	NULL
Rat-l1	NULL
cells	NULL
under	NULL
low	NULL
serum	NULL
conditions	NULL
in	NULL
which	NULL
c-myc-expressing	NULL
Rat-l1	NULL
cells	NULL
remained	NULL
in	NULL
cycle	NULL
and	NULL
underwent	NULL
apoptosis	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
apoptotic	NULL
process	NULL
initiated	NULL
by	NULL
E2a-Pbx1	NULL
does	NULL
not	NULL
breach	NULL
a	NULL
p53	NULL
checkpoint	NULL
and	NULL
is	NULL
unlikely	NULL
to	NULL
involve	NULL
a	NULL
reflexive	NULL
response	NULL
to	NULL
primary	NULL
abnormalities	NULL
of	NULL
cell	NULL
cycle	NULL
control	NULL
.	NULL

Our	NULL
findings	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
reported	NULL
very	NULL
low	NULL
incidence	NULL
of	NULL
p53	NULL
mutations	NULL
in	NULL
t	NULL
(	NULL
1l	NULL
;	NULL
19	NULL
)	NULL
-bearing	NULL
human	NULL
leukemias	NULL
at	NULL
diagnosis	NULL
(	NULL
Kawamura	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
EZa-Pbxl	NULL
to	NULL
render	NULL
lymphoid	NULL
progenitors	NULL
highly	NULL
susceptible	NULL
to	NULL
apoptosis	NULL
would	NULL
appear	NULL
to	NULL
be	NULL
inconsistent	NULL
with	NULL
its	NULL
potential	NULL
role	NULL
in	NULL
the	NULL
leukemic	NULL
transformation	NULL
of	NULL
the	NULL
same	NULL
cell	NULL
type	NULL
.	NULL

However	NULL
,	NULL
our	NULL
studies	NULL
provide	NULL
a	NULL
plausible	NULL
mechanism	NULL
by	NULL
which	NULL
cells	NULL
expressing	NULL
EZa-Pbx1	NULL
may	NULL
escape	NULL
its	NULL
apoptotic	NULL
effects	NULL
.	NULL

Given	NULL
that	NULL
elevated	NULL
levels	NULL
of	NULL
BCL2	NULL
suppress	NULL
EZa-Pbx1-induced	NULL
apoptosis	NULL
in	NULL
Reh	NULL
cells	NULL
,	NULL
pre-B	NULL
cells	NULL
that	NULL
have	NULL
acquired	NULL
t	NULL
(	NULL
1	NULL
;	NULL
19	NULL
)	NULL
translocations	NULL
may	NULL
be	NULL
similarly	NULL
protected	NULL
by	NULL
endogenously	NULL
high	NULL
levels	NULL
of	NULL
death	NULL
suppressors	NULL
(	NULL
such	NULL
as	NULL
BCL2	NULL
or	NULL
functionally	NULL
analogous	NULL
family	NULL
members	NULL
)	NULL
relative	NULL
to	NULL
death	NULL
accelerators	NULL
such	NULL
as	NULL
BAX	NULL
.	NULL

Most	NULL
t	NULL
(	NULL
1	NULL
;	NULL
19	NULL
)	NULL
leukemias	NULL
display	NULL
maturation	NULL
arrest	NULL
at	NULL
the	NULL
pre-B	NULL
cell	NULL
stage	NULL
of	NULL
differentiation	NULL
with	NULL
expression	NULL
of	NULL
cytoplasmic	NULL
but	NULL
not	NULL
surface	NULL
Ig	NULL
mu	NULL
chains	NULL
.	NULL

Pre-B	NULL
cells	NULL
typically	NULL
express	NULL
IL7	NULL
receptors	NULL
and	NULL
are	NULL
exquisitely	NULL
responsive	NULL
to	NULL
this	NULL
cytokine	NULL
which	NULL
has	NULL
potent	NULL
survival	NULL
effects	NULL
.	NULL

Therefore	NULL
,	NULL
concurrent	NULL
physiologic	NULL
survival	NULL
signals	NULL
may	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
-	NULL
EZa-Pbxl-associated	NULL
leukemogenesis	NULL
and	NULL
potentially	NULL
account	NULL
for	NULL
the	NULL
association	NULL
of	NULL
the	NULL
t	NULL
(	NULL
1	NULL
;	NULL
19	NULL
)	NULL
with	NULL
a	NULL
characteristic	NULL
subset	NULL
of	NULL
human	NULL
pediatric	NULL
leukemias	NULL
.	NULL

The	NULL
potential	NULL
ability	NULL
of	NULL
synergistic	NULL
interaction	NULL
of	NULL
Bcl-2	NULL
and	NULL
E2a-Pbx1	NULL
to	NULL
alter	NULL
the	NULL
growth	NULL
of	NULL
cells	NULL
is	NULL
currently	NULL
being	NULL
investigated	NULL
in	NULL
transgenic	NULL
animal	NULL
models	NULL
.	NULL

The	NULL
availability	NULL
of	NULL
in	NULL
vitro	NULL
or	NULL
animal	NULL
models	NULL
of	NULL
pre-B	NULL
cell	NULL
transformation	NULL
by	NULL
EZa-Pbx1	NULL
as	NULL
well	NULL
as	NULL
the	NULL
identification	NULL
of	NULL
bona	NULL
fide	NULL
target	NULL
genes	NULL
would	NULL
significantly	NULL
enhance	NULL
efforts	NULL
to	NULL
dissect	NULL
the	NULL
apoptotic	NULL
and	NULL
oncogenic	NULL
signaling	NULL
cascades	NULL
initiated	NULL
by	NULL
this	NULL
chimeric	NULL
transcription	NULL
factor	NULL
.	NULL

Materials	NULL
and	NULL
methods	NULL
Expression	NULL
constructs	NULL
and	NULL
stable	NULL
transfections	NULL
The	NULL
full-length	NULL
EZ2a-Pbxla	NULL
and	NULL
EZa-Pbxlb	NULL
cDNAs	NULL
were	NULL
cloned	NULL
into	NULL
the	NULL
BamHI	NULL
site	NULL
of	NULL
MRE-pNEO	NULL
.	NULL

The	NULL
E2A-PBX1	NULL
mutant	NULL
HD	NULL
;	NULL
Â»	NULL
-	NULL
;	NULL
1	NULL
,	NULL
was	NULL
made	NULL
by	NULL
partially	NULL
digesting	NULL
the	NULL
E2a-Pbx1b	NULL
cDNA	NULL
with	NULL
PvuII	NULL
eliminating	NULL
the	NULL
region	NULL
3	NULL
'	NULL
of	NULL
the	NULL
fourth	NULL
Pvull	NULL
site	NULL
and	NULL
inserting	NULL
a	NULL
stop	NULL
codon	NULL
by	NULL
PCR	NULL
.	NULL

The	NULL
E2a-Pbx1	NULL
mutants	NULL
A232-430	NULL
was	NULL
reported	NULL
previously	NULL
as	NULL
A621-819	NULL
(	NULL
Monica	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

A	NULL
homeodomain	NULL
deletion	NULL
mutant	NULL
of	NULL
E2a-Pbxlb	NULL
(	NULL
1IbAHD	NULL
)	NULL
was	NULL
constructed	NULL
by	NULL
replacing	NULL
the	NULL
carboxy	NULL
terminus	NULL
of	NULL
EZa-Pbxla	NULL
homeodomain	NULL
mutant	NULL
A621-683	NULL
(	NULL
Monica	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
with	NULL
the	NULL
carboxy	NULL
terminal	NULL
Neo	NULL
!	NULL

fragment	NULL
of	NULL
Pbx1b	NULL
.	NULL

The	NULL
construct	NULL
was	NULL
produced	NULL
by	NULL
using	NULL
PCR	NULL
to	NULL
add	NULL
a	NULL
stop	NULL
codon	NULL
immediately	NULL
downstream	NULL
from	NULL
the	NULL
homeodomain	NULL
of	NULL
the	NULL
previously	NULL
reported	NULL
mutant	NULL
A477-620/708-819	NULL
(	NULL
Monica	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

All	NULL
mutant	NULL
E2a-Pbx1	NULL
cDNAs	NULL
and	NULL
the	NULL
E2a-HIf	NULL
cDNA	NULL
(	NULL
Hunger	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
were	NULL
cloned	NULL
into	NULL
the	NULL
BamHI	NULL
site	NULL
of	NULL
MRE-pNEO	NULL
by	NULL
blunt-end	NULL
ligation	NULL
.	NULL

E2a-Pbx1b	NULL
and	NULL
c-mye	NULL
were	NULL
blunt-end	NULL
ligated	NULL
into	NULL
the	NULL
EcoRI	NULL
site	NULL
of	NULL
the	NULL
retroviral	NULL
vector	NULL
COS-MSV/NEO	NULL
which	NULL
was	NULL
used	NULL
to	NULL
prepare	NULL
retroviral	NULL
stocks	NULL
employed	NULL
for	NULL
infection	NULL
of	NULL
Rat-l	NULL
fibroblasts	NULL
.	NULL

COS-MSV/NEO-E2a-Pbx1b	NULL
or	NULL
-comyc	NULL
were	NULL
transiently	NULL
transfected	NULL
into	NULL
the	NULL
ectropic	NULL
helper	NULL
lines	NULL
BOSC	NULL
using	NULL
the	NULL
calcium	NULL
phosphate	NULL
technique	NULL
.	NULL

Viral	NULL
supernatants	NULL
were	NULL
collected	NULL
and	NULL
added	NULL
to	NULL
logarithmically	NULL
growing	NULL
Rat-1	NULL
fibroblasts	NULL
.	NULL

Stable	NULL
clones	NULL
were	NULL
selected	NULL
in	NULL
500	NULL
ug/ml	NULL
G418	NULL
sulfate	NULL
and	NULL
individual	NULL
clones	NULL
were	NULL
isolated	NULL
.	NULL

Reh	NULL
cells	NULL
were	NULL
electroporated	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
4	NULL
x	NULL
10	NULL
``	NULL
cells/ml	NULL
using	NULL
20	NULL
ug	NULL
linearized	NULL
plasmid	NULL
DNA	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
once	NULL
in	NULL
serum-free	NULL
RPMI	NULL
and	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
RPMI	NULL
for	NULL
10	NULL
min	NULL
prior	NULL
to	NULL
electroporation	NULL
which	NULL
was	NULL
performed	NULL
using	NULL
a	NULL
BioRad	NULL
Gene	NULL
Pulser	NULL
with	NULL
capacitance	NULL
extender	NULL
(	NULL
Hercules	NULL
,	NULL
CA	NULL
)	NULL
at	NULL
400	NULL
V	NULL
and	NULL
960	NULL
uFD	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Following	NULL
electroporation	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
RPMI	NULL
for	NULL
10	NULL
min	NULL
then	NULL
cultured	NULL
for	NULL
48	NULL
h	NULL
in	NULL
RPMI	NULL
1640	NULL
containing	NULL
10	NULL
%	NULL
FCS	NULL
(	NULL
R-10	NULL
)	NULL
.	NULL

Stable	NULL
transfectants	NULL
were	NULL
then	NULL
selected	NULL
in	NULL
medium	NULL
containing	NULL
500	NULL
ug/ml	NULL
G418-sulfate	NULL
for	NULL
2	NULL
weeks	NULL
at	NULL
which	NULL
point	NULL
single	NULL
cell	NULL
clones	NULL
were	NULL
isolated	NULL
by	NULL
either	NULL
FACS	NULL
sorting	NULL
or	NULL
limiting	NULL
dilution	NULL
into	NULL
96	NULL
well	NULL
plates	NULL
.	NULL

Stable	NULL
cell	NULL
clones	NULL
were	NULL
maintained	NULL
in	NULL
R-10	NULL
containing	NULL
200	NULL
ug/ml	NULL
G418-sulfate	NULL
.	NULL

Expression	NULL
and	NULL
immunoblotting	NULL
of	NULL
protein	NULL
Stably	NULL
transfected	NULL
Reh	NULL
clones	NULL
were	NULL
induced	NULL
with	NULL
zinc	NULL
sulfate	NULL
at	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
100	NULL
uM	NULL
in	NULL
R-10	NULL
.	NULL

Induced	NULL
cells	NULL
were	NULL
collected	NULL
at	NULL
specified	NULL
timepoints	NULL
,	NULL
washed	NULL
in	NULL
phosphate	NULL
buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
,	NULL
lysed	NULL
immediately	NULL
in	NULL
1x	NULL
sample	NULL
buffer	NULL
(	NULL
50	NULL
mm	NULL
Tris-Cl	NULL
(	NULL
pH	NULL
6.8	NULL
)	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
2	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
)	NULL
and	NULL
boiled	NULL
for	NULL
5	NULL
min	NULL
.	NULL

The	NULL
lysates	NULL
were	NULL
sonicated	NULL
and	NULL
the	NULL
OD	NULL
;	NULL
;	NULL
,	NULL
was	NULL
determined	NULL
.	NULL

Ten	NULL
micrograms	NULL
of	NULL
total	NULL
cellular	NULL
protein	NULL
were	NULL
subjected	NULL
to	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
PAGE	NULL
)	NULL
followed	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
using	NULL
an	NULL
anti-E2a	NULL
monoclonal	NULL
antibody	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
Jacobs	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

The	NULL
homeodomain	NULL
lacking	NULL
construct	NULL
(	NULL
1bAHD	NULL
)	NULL
was	NULL
detected	NULL
using	NULL
a	NULL
Pbxlb-specific	NULL
monoclonal	NULL
antibody	NULL
(	NULL
Y	NULL
)	NULL
and	NULL
MLC	NULL
,	NULL
unpublished	NULL
)	NULL
.	NULL

Western	NULL
blot	NULL
analyses	NULL
to	NULL
assess	NULL
various	NULL
modulators	NULL
of	NULL
apoptosis	NULL
were	NULL
performed	NULL
under	NULL
similar	NULL
conditions	NULL
employing	NULL
a	NULL
rabbit	NULL
antiserum	NULL
specific	NULL
for	NULL
Bax	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
,	NULL
an	NULL
anti-Bel-2	NULL
monoclonal	NULL
antibody	NULL
(	NULL
Dako	NULL
Corp.	NULL
)	NULL
,	NULL
anti-Mcl-1	NULL
antisera	NULL
(	NULL
Dr	NULL
John	NULL
Reed	NULL
,	NULL
LaJolla	NULL
Cancer	NULL
Research	NULL
Institute	NULL
)	NULL
,	NULL
an	NULL
anti-p53	NULL
monoclonal	NULL
antibody	NULL
(	NULL
PharMingen	NULL
)	NULL
,	NULL
and	NULL
anti-PARP	NULL
monoclonal	NULL
antibody	NULL
(	NULL
Dr	NULL
Guy	NULL
Poirier	NULL
,	NULL
Centre	NULL
Hospital	NULL
,	NULL
University	NULL
Laval	NULL
)	NULL
.	NULL

Rat-1	NULL
fibroblasts	NULL
were	NULL
collected	NULL
using	NULL
cell	NULL
scraping	NULL
buffer	NULL
(	NULL
150	NULL
mm	NULL
NaCl	NULL
,	NULL
40	NULL
mm	NULL
Tris	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
)	NULL
and	NULL
lysed	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Western	NULL
blot	NULL
detection	NULL
of	NULL
EZa-Pbxlb	NULL
production	NULL
within	NULL
Rat-l	NULL
fibroblasts	NULL
was	NULL
accomplished	NULL
using	NULL
an	NULL
anti-E2a	NULL
monoclonal	NULL
antibody	NULL
.	NULL

Assessment	NULL
of	NULL
apoptosis	NULL
Logarithmically	NULL
growing	NULL
,	NULL
stably	NULL
transfected	NULL
cells	NULL
containing	NULL
full-length	NULL
and	NULL
mutant	NULL
EZa-Pbx1	NULL
constructs	NULL
were	NULL
References	NULL
Aronheim	NULL
A	NULL
,	NULL
Shiran	NULL
R	NULL
,	NULL
Rosen	NULL
A	NULL
and	NULL
Walker	NULL
MD	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
90	NULL
,	NULL
8063-8067	NULL
.	NULL

Chang	NULL
C-P	NULL
,	NULL
Brocchieri	NULL
L	NULL
,	NULL
Shen	NULL
W-F	NULL
,	NULL
Largman	NULL
C	NULL
and	NULL
Cleary	NULL
ML	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
16	NULL
,	NULL
1734-1745	NULL
.	NULL

Chang	NULL
C-P	NULL
,	NULL
Shen	NULL
W-F	NULL
,	NULL
Rozenfeld	NULL
S	NULL
,	NULL
Lawrence	NULL
HJ	NULL
,	NULL
Largman	NULL
C	NULL
and	NULL
Cleary	NULL
ML	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

,	NULL
9	NULL
,	NULL
663-674	NULL
.	NULL

Chang	NULL
C-P	NULL
,	NULL
DeVivo	NULL
I	NULL
and	NULL
Cleary	NULL
ML	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
In	NULL
press	NULL
.	NULL

Apoptsosis	NULL
induced	NULL
in	NULL
vitro	NULL
by	NULL
EZa-Pbx1	NULL
KS	NULL
Smith	NULL
et	NULL
al	NULL
treated	NULL
with	NULL
100	NULL
um	NULL
ZnSO	NULL
,	NULL
for	NULL
72h	NULL
at	NULL
an	NULL
initial	NULL
concentration	NULL
of	NULL
3	NULL
x	NULL
10Â°	NULL
cells/ml	NULL
.	NULL

Triplicate	NULL
samplings	NULL
were	NULL
removed	NULL
at	NULL
24	NULL
h	NULL
intervals	NULL
and	NULL
scored	NULL
for	NULL
viable	NULL
and	NULL
apoptotic	NULL
cells	NULL
using	NULL
a	NULL
hemocytometer	NULL
and	NULL
a	NULL
Nikon	NULL
TMS	NULL
inverted	NULL
microscope	NULL
equipped	NULL
with	NULL
a	NULL
Ph	NULL
1	NULL
phase	NULL
annular	NULL
ring	NULL
for	NULL
contrast	NULL
at	NULL
150	NULL
x	NULL
magnification	NULL
.	NULL

For	NULL
isolation	NULL
of	NULL
chromosomal	NULL
DNA	NULL
and	NULL
assessment	NULL
of	NULL
oligonucleosomal	NULL
degradation	NULL
,	NULL
stably	NULL
transfected	NULL
Reh	NULL
clones	NULL
were	NULL
treated	NULL
with	NULL
100	NULL
um	NULL
ZnSO	NULL
,	NULL
for	NULL
36	NULL
h	NULL
and	NULL
washed	NULL
once	NULL
in	NULL
PBS	NULL
.	NULL

Cells	NULL
were	NULL
disrupted	NULL
in	NULL
lysis	NULL
buffer	NULL
(	NULL
50	NULL
mm	NULL
Tris	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
0.5	NULL
%	NULL
SDS	NULL
,	NULL
100	NULL
um	NULL
NaCl	NULL
,	NULL
2	NULL
mm	NULL
EDTA	NULL
(	NULL
pH	NULL
8.0	NULL
)	NULL
,	NULL
100	NULL
ug/ml	NULL
proteinase	NULL
K	NULL
,	NULL
100	NULL
ug	NULL
RNase	NULL
A	NULL
)	NULL
and	NULL
heated	NULL
overnight	NULL
at	NULL
60Â°C	NULL
.	NULL

The	NULL
lysate	NULL
was	NULL
brought	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
1.25	NULL
M	NULL
potassium	NULL
acetate	NULL
and	NULL
extracted	NULL
once	NULL
with	NULL
phenol/chloroform	NULL
.	NULL

The	NULL
DNA	NULL
was	NULL
precipitated	NULL
with	NULL
ethanol	NULL
,	NULL
resuspended	NULL
in	NULL
dH	NULL
;	NULL
,	NULL
O	NULL
containing	NULL
100	NULL
ug	NULL
RNase	NULL
A	NULL
and	NULL
electrophoresed	NULL
through	NULL
1.5	NULL
%	NULL
agarose-ethidium	NULL
bromide	NULL
gels	NULL
in	NULL
tris-acetate	NULL
buffer	NULL
.	NULL

For	NULL
bright	NULL
field	NULL
microscopy	NULL
,	NULL
stably	NULL
transfected	NULL
Reh	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
100	NULL
um	NULL
ZnSO	NULL
,	NULL
for	NULL
36	NULL
h	NULL
and	NULL
photographed	NULL
at	NULL
200	NULL
x	NULL
magnification	NULL
using	NULL
a	NULL
Nikon	NULL
Microphot-FXA	NULL
camera	NULL
.	NULL

Cell	NULL
cycle	NULL
analysis	NULL
FACS	NULL
analysis	NULL
to	NULL
determine	NULL
DNA	NULL
content	NULL
of	NULL
RAT-1	NULL
cells	NULL
was	NULL
performed	NULL
by	NULL
lysing	NULL
72	NULL
h	NULL
serum-starved	NULL
or	NULL
log-phase	NULL
cells	NULL
in	NULL
DNA	NULL
cell	NULL
cycle	NULL
buffer	NULL
(	NULL
PBS	NULL
containing	NULL
100	NULL
ug/ml	NULL
Rnase	NULL
A	NULL
,	NULL
10	NULL
ug/ml	NULL
propidium	NULL
iodide	NULL
,	NULL
and	NULL
1	NULL
%	NULL
Tween-20	NULL
)	NULL
and	NULL
incubating	NULL
overnight	NULL
at	NULL
4Â°C	NULL
.	NULL

Nuclei	NULL
were	NULL
analysed	NULL
on	NULL
a	NULL
Becton-Dickinson	NULL
FACS-Calibur	NULL
and	NULL
DNA	NULL
content	NULL
was	NULL
calculated	NULL
using	NULL
ModFit	NULL
software	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
San	NULL
Jose	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
percentage	NULL
of	NULL
cells	NULL
in	NULL
S	NULL
phase	NULL
,	NULL
Rat-1/EZa-Pbxlb	NULL
,	NULL
c-mye	NULL
and	NULL
vector-only	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
DMEM-0.1	NULL
%	NULL
FCS	NULL
(	NULL
D-0.1	NULL
)	NULL
for	NULL
48	NULL
h	NULL
then	NULL
metabolically	NULL
labeled	NULL
in	NULL
D-0.1	NULL
containing	NULL
100	NULL
uM	NULL
bromo-deoxyuridine	NULL
(	NULL
BrdU	NULL
)	NULL
for	NULL
2	NULL
h.	NULL
Adherent	NULL
cells	NULL
were	NULL
then	NULL
washed	NULL
and	NULL
fixed	NULL
in	NULL
70	NULL
%	NULL
ethanol	NULL
at	NULL
-20Â°C	NULL
for	NULL
10	NULL
min	NULL
and	NULL
treated	NULL
with	NULL
2N	NULL
HCL/0.8	NULL
%	NULL
Tween-20	NULL
.	NULL

Samples	NULL
were	NULL
neutralized	NULL
in	NULL
100	NULL
mM	NULL
NaB,0	NULL
;	NULL
-10H,0	NULL
for	NULL
10	NULL
min	NULL
and	NULL
stained	NULL
with	NULL
a	NULL
FITC-conjugated	NULL
monoclonal	NULL
antibody	NULL
directed	NULL
against	NULL
BrdU	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
cells	NULL
traversing	NULL
S	NULL
phase	NULL
was	NULL
determined	NULL
microscopically	NULL
by	NULL
quantitating	NULL
FITC-positive	NULL
cells	NULL
as	NULL
a	NULL
fraction	NULL
of	NULL
total	NULL
cells	NULL
stained	NULL
with	NULL
Hoechst	NULL
nuclear	NULL
counterstain	NULL
.	NULL

Acknowledgements	NULL
We	NULL
thank	NULL
Immaculata	NULL
De	NULL
Vivo	NULL
for	NULL
making	NULL
available	NULL
transformation	NULL
data	NULL
prior	NULL
to	NULL
its	NULL
publication	NULL
,	NULL
John	NULL
Reed	NULL
and	NULL
Guy	NULL
Poirier	NULL
for	NULL
kindly	NULL
providing	NULL
immune	NULL
sera	NULL
directed	NULL
against	NULL
Mcl-1	NULL
and	NULL
PARP	NULL
,	NULL
respectively	NULL
,	NULL
Richard	NULL
Palmiter	NULL
for	NULL
the	NULL
MRE-pNEO	NULL
plasmid	NULL
,	NULL
and	NULL
Kathleen	NULL
Kelly	NULL
for	NULL
the	NULL
c-mye	NULL
cDNA	NULL
.	NULL

We	NULL
thank	NULL
Samuel	NULL
Chessier	NULL
for	NULL
cell	NULL
cycle	NULL
reagents	NULL
and	NULL
Phil	NULL
Verzola	NULL
for	NULL
photography	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
(	NULL
CA42971	NULL
)	NULL
.	NULL

KSS	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Research	NULL
Service	NULL
Award	NULL
(	NULL
CAG66284	NULL
)	NULL
.	NULL

YJ	NULL
was	NULL
supported	NULL
by	NULL
NIH	NULL
Training	NULL
Grant	NULL
(	NULL
CAOQQ151	NULL
)	NULL
.	NULL

MLC	NULL
is	NULL
a	NULL
scholar	NULL
of	NULL
the	NULL
Leukemia	NULL
Society	NULL
of	NULL
America	NULL
.	NULL

Cleary	NULL
ML	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
66	NULL
,	NULL
619-622	NULL
.	NULL

Debbas	NULL
M	NULL
and	NULL
White	NULL
E.	NULL
(	NULL
1993	NULL
)	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

,	NULL
7	NULL
,	NULL
546-554	NULL
.	NULL

Dedera	NULL
DA	NULL
,	NULL
Waller	NULL
EK	NULL
,	NULL
Lebrun	NULL
DP	NULL
,	NULL
Sen-Majumdar	NULL
A	NULL
,	NULL
Stevens	NULL
ME	NULL
,	NULL
Barsh	NULL
GS	NULL
and	NULL
Cleary	NULL
ML	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
74	NULL
,	NULL
833-843	NULL
.	NULL

Ellis	NULL
R	NULL
,	NULL
Yuan	NULL
J	NULL
and	NULL
Horvitz	NULL
HR	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
.	NULL

Ann	NULL
.	NULL

Rev	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

,	NULL
7	NULL
,	NULL
663-698	NULL
.	NULL

2925	NULL
Apoptsosis	NULL
induced	NULL
in	NULL
vitro	NULL
by	NULL
EZa-Pbx1	NULL
KS	NULL
Smith	NULL
et	NULL
al	NULL
2926	NULL
Evan	NULL
GI	NULL
,	NULL
Wyllie	NULL
AH	NULL
,	NULL
Gilbert	NULL
CS	NULL
,	NULL
Littlewood	NULL
TD	NULL
,	NULL
Land	NULL
H	NULL
,	NULL
Brooks	NULL
M	NULL
,	NULL
Waters	NULL
CM	NULL
,	NULL
Penn	NULL
LZ	NULL
and	NULL
Hancock	NULL
DC	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
69	NULL
,	NULL
119-128	NULL
.	NULL

Harrington	NULL
EA	NULL
,	NULL
Fanidi	NULL
A	NULL
and	NULL
Evan	NULL
GI	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Genet	NULL
.	NULL

Dev	NULL
.	NULL

,	NULL
4	NULL
,	NULL
120-129	NULL
.	NULL

Hermeking	NULL
H	NULL
and	NULL
Eick	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

Science	NULL
,	NULL
265	NULL
,	NULL
2091-2093	NULL
.	NULL

Hunger	NULL
SP	NULL
,	NULL
Brown	NULL
R	NULL
and	NULL
Cleary	NULL
ML	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
14	NULL
,	NULL
5986-5996	NULL
.	NULL

Hunger	NULL
SP	NULL
,	NULL
Ohyashiki	NULL
K	NULL
,	NULL
Toyama	NULL
K	NULL
and	NULL
Cleary	NULL
ML	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

,	NULL
6	NULL
,	NULL
1608-1620	NULL
.	NULL

Inaba	NULL
T	NULL
,	NULL
Inukai	NULL
T	NULL
,	NULL
Yoshihara	NULL
T	NULL
,	NULL
Seyschab	NULL
H	NULL
,	NULL
Ashmun	NULL
RA	NULL
,	NULL
Canman	NULL
CE	NULL
,	NULL
Laken	NULL
SJ	NULL
,	NULL
Kastan	NULL
MB	NULL
and	NULL
Look	NULL
AT	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Nature	NULL
,	NULL
382	NULL
,	NULL
541-544	NULL
.	NULL

Inaba	NULL
T	NULL
,	NULL
Shapiro	NULL
LH	NULL
,	NULL
Funabiki	NULL
T	NULL
,	NULL
Sinclair	NULL
AE	NULL
,	NULL
Jones	NULL
BG	NULL
,	NULL
Ashum	NULL
RA	NULL
and	NULL
Look	NULL
AT	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
14	NULL
,	NULL
3403-3413	NULL
.	NULL

Jacobs	NULL
Y	NULL
,	NULL
Vierra	NULL
C	NULL
and	NULL
Nelson	NULL
C.	NULL
(	NULL
1993	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
13	NULL
,	NULL
7321-7333	NULL
.	NULL

Kadesch	NULL
T.	NULL
(	NULL
1992	NULL
)	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
,	NULL
13	NULL
,	NULL
31-36	NULL
.	NULL

Kamps	NULL
MP	NULL
,	NULL
Murre	NULL
C	NULL
,	NULL
Sun	NULL
X-H	NULL
and	NULL
Baltimore	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
60	NULL
,	NULL
547-556	NULL
.	NULL

Kamps	NULL
MP	NULL
,	NULL
Look	NULL
AT	NULL
and	NULL
Baltimore	NULL
D.	NULL
(	NULL
1991	NULL
)	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

,	NULL
5	NULL
,	NULL
358-368	NULL
.	NULL

Kamps	NULL
MP	NULL
,	NULL
Wright	NULL
DD	NULL
and	NULL
Lu	NULL
Q	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Oncogene	NULL
,	NULL
12	NULL
,	NULL
19-30	NULL
.	NULL

Kastan	NULL
MB	NULL
,	NULL
Onyekwere	NULL
O	NULL
,	NULL
Sidransky	NULL
D	NULL
,	NULL
Vogelstein	NULL
B	NULL
and	NULL
Craig	NULL
RW	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
51	NULL
,	NULL
6304-6311	NULL
.	NULL

Kaufmann	NULL
SH	NULL
,	NULL
Desnoyers	NULL
S	NULL
,	NULL
Ottaviano	NULL
Y	NULL
,	NULL
Davidson	NULL
NE	NULL
and	NULL
Poirier	NULL
GG	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
53	NULL
,	NULL
3976-3985	NULL
.	NULL

Kawamura	NULL
M	NULL
,	NULL
Kikuchi	NULL
A	NULL
,	NULL
Kobayashi	NULL
S	NULL
,	NULL
Hanada	NULL
R	NULL
,	NULL
Yamamoto	NULL
K	NULL
,	NULL
Horibe	NULL
K	NULL
,	NULL
Shikano	NULL
T	NULL
,	NULL
Ueda	NULL
K	NULL
,	NULL
Hayashi	NULL
K.	NULL
,	NULL
Sekiya	NULL
T	NULL
and	NULL
Hayashi	NULL
Y	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Blood	NULL
,	NULL
85	NULL
,	NULL
2546-2552	NULL
.	NULL

Lebrun	NULL
DP	NULL
and	NULL
Cleary	NULL
ML	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

Oncogene	NULL
,	NULL
9	NULL
,	NULL
1641-1647	NULL
.	NULL

Lippke	NULL
JA	NULL
,	NULL
Gu	NULL
Y	NULL
,	NULL
Sarnecki	NULL
C	NULL
,	NULL
Caron	NULL
PR	NULL
and	NULL
Su	NULL
MS-S.	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
271	NULL
,	NULL
1825-1828	NULL
.	NULL

Lowe	NULL
SW	NULL
,	NULL
Ruley	NULL
HE	NULL
,	NULL
Jacks	NULL
T	NULL
and	NULL
Housman	NULL
DE	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
74	NULL
,	NULL
957-967	NULL
.	NULL

Lu	NULL
Q	NULL
,	NULL
Knoepfler	NULL
PS	NULL
,	NULL
Scheele	NULL
J	NULL
,	NULL
Wright	NULL
DD	NULL
and	NULL
Kamps	NULL
MP	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
15	NULL
,	NULL
3786-3795	NULL
.	NULL

Mann	NULL
RS	NULL
and	NULL
Chan	NULL
S-K.	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

Trends	NULL
Genet	NULL
.	NULL

,	NULL
12	NULL
,	NULL
258-262	NULL
.	NULL

Monica	NULL
K	NULL
,	NULL
Galili	NULL
N	NULL
,	NULL
Nourse	NULL
J	NULL
,	NULL
Saltman	NULL
D	NULL
and	NULL
Cleary	NULL
ML	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
11	NULL
,	NULL
6149-6157	NULL
.	NULL

Monica	NULL
K	NULL
,	NULL
Lebrun	NULL
DP	NULL
,	NULL
Dedera	NULL
DA	NULL
,	NULL
Brown	NULL
R	NULL
and	NULL
Cleary	NULL
ML	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
14	NULL
,	NULL
8304-8314	NULL
.	NULL

Nourse	NULL
J	NULL
,	NULL
Mellentin	NULL
JD	NULL
,	NULL
Galili	NULL
N	NULL
,	NULL
Wilkinson	NULL
J	NULL
,	NULL
Stanbridge	NULL
E	NULL
,	NULL
Smith	NULL
SD	NULL
and	NULL
Cleary	NULL
ML	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
60	NULL
,	NULL
535-546	NULL
.	NULL

Nunez	NULL
G	NULL
and	NULL
Clarke	NULL
MF	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

Trends	NULL
Cell	NULL
Biol	NULL
.	NULL

,	NULL
4	NULL
,	NULL
399	NULL
403	NULL
.	NULL

Peers	NULL
B	NULL
,	NULL
Sharma	NULL
S	NULL
,	NULL
Johnson	NULL
T	NULL
,	NULL
Kamps	NULL
M	NULL
and	NULL
Montminy	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
15	NULL
,	NULL
7091-7097	NULL
.	NULL

Peverali	NULL
FA	NULL
,	NULL
Ramqvist	NULL
T	NULL
,	NULL
Saffrich	NULL
R	NULL
,	NULL
Pepperkok	NULL
R	NULL
,	NULL
Barone	NULL
MV	NULL
and	NULL
Philipson	NULL
L.	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
13	NULL
,	NULL
4291-4301	NULL
.	NULL

Phelan	NULL
ML	NULL
,	NULL
Rambaldi	NULL
I	NULL
and	NULL
Featherstone	NULL
MS.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
15	NULL
,	NULL
3989-3997	NULL
.	NULL

Popperl	NULL
H	NULL
,	NULL
Bienz	NULL
M	NULL
,	NULL
Studer	NULL
M	NULL
,	NULL
Chan	NULL
S-K	NULL
,	NULL
Aparicio	NULL
S	NULL
,	NULL
Brenner	NULL
S	NULL
,	NULL
Mann	NULL
RS	NULL
and	NULL
Krumlauf	NULL
R.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
81	NULL
,	NULL
1031-1042	NULL
.	NULL

Quong	NULL
MW	NULL
,	NULL
Massari	NULL
ME	NULL
,	NULL
Swart	NULL
R	NULL
and	NULL
Murre	NULL
C.	NULL
(	NULL
1993	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
13	NULL
,	NULL
792-800	NULL
.	NULL

Rauskolb	NULL
C	NULL
,	NULL
Peifer	NULL
M	NULL
and	NULL
Wieschaus	NULL
E.	NULL
(	NULL
1993	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
74	NULL
,	NULL
1101-1112	NULL
.	NULL

Rauskolb	NULL
C	NULL
and	NULL
Wieschaus	NULL
E.	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
13	NULL
,	NULL
3561	NULL
3569	NULL
.	NULL

Schlegel	NULL
J	NULL
,	NULL
Peters	NULL
I	NULL
,	NULL
Orrenius	NULL
S	NULL
,	NULL
Miller	NULL
DK	NULL
,	NULL
Thornberry	NULL
NA	NULL
,	NULL
Yamin	NULL
T-T	NULL
and	NULL
Nicholson	NULL
DW	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
271	NULL
,	NULL
1841-1844	NULL
.	NULL

Shan	NULL
B	NULL
and	NULL
Lee	NULL
W-H.	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
14	NULL
,	NULL
8166-8173	NULL
.	NULL

Wagner	NULL
AJ	NULL
,	NULL
Kokontis	NULL
JM	NULL
and	NULL
Hay	NULL
N.	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

,	NULL
8	NULL
,	NULL
2817-2830	NULL
.	NULL

Wolf	NULL
D	NULL
and	NULL
Rotter	NULL
V.	NULL
(	NULL
1985	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
82	NULL
,	NULL
790-794	NULL
.	NULL

Zou	NULL
H	NULL
and	NULL
Niswander	NULL
L.	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

Science	NULL
,	NULL
272	NULL
,	NULL
738-741	NULL
.	NULL

